Neck masses differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 51: Line 51:
*Non-pulsatile
*Non-pulsatile
*Fluctuant
*Fluctuant
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*A pit at the opening of the [[cyst]]
*A pit at the opening of the [[cyst]]
Line 60: Line 59:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[CT]]: Well defined fluid [[attenuation]] with slight enhancement of the [[capsule]]
*[[CT]]: Well defined fluid [[attenuation]] with slight enhancement of the [[capsule]]
*[[Ultrasound]]: Typical features of a [[cyst]] are seen
*[[Ultrasound]]: Typical features of a [[cyst]] are seen
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 86: Line 84:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Squamous epithelium|Squamous]] or ciliated [[pseudostratified columnar]] lining
*[[Squamous epithelium|Squamous]] or ciliated [[pseudostratified columnar]] lining
*Foci of [[thyroid gland]] tissue
*Foci of [[thyroid gland]] tissue
*[[Granulation tissue]] or [[giant cells]] if it gets infected
*[[Granulation tissue]] or [[giant cells]] if it gets infected
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 102: Line 98:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Age]]: birth − 2 yrs
*[[Age]]: birth − 2 yrs
*[[Females]]>[[males]]
*[[Females]]>[[males]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 111: Line 106:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Firm
*Firm
*Rubbery
*Rubbery
*Well-demarcated
*Well-demarcated
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Blanching]]
*[[Blanching]]
*[[Telangiectasias]]
*[[Telangiectasias]]
*[[Erythematous]] patch
*[[Erythematous]] patch
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*GLUT-1
*GLUT-1
*[[VEGF]]
*[[VEGF]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Lined by non atypical [[endothelial cells]]
*Lined by non atypical [[endothelial cells]]
*Vascular structures with [[RBC]]
*Vascular structures with [[RBC]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Ultrasound]]: High flow with vascular channels
*[[Ultrasound]]: High flow with vascular channels
*[[MRI]]: With or without Gd is the modality of choice
*[[MRI]]: With or without Gd is the modality of choice
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 143: Line 130:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Incidence]]: 1 in 2000 to 5000 births
*[[Incidence]]: 1 in 2000 to 5000 births
*Sex: No predilection
*Sex: No predilection
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Venous]]: Present with a bluish [[swelling]]
*[[Venous]]: Present with a bluish [[swelling]]
*AV malformations: Present with purple/red [[swelling]]
*AV malformations: Present with purple/red [[swelling]]
| align="center" style="background:#F5F5F5;" | ±
| align="center" style="background:#F5F5F5;" | ±
Line 153: Line 138:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Soft
*Soft
*Compressible
*Compressible
*Non-tender
*Non-tender
*Venous: No thrill,↑ in size on [[valsalva]]
*Venous: No thrill,↑ in size on [[valsalva]]
*AV malformations: [[Thrill]], warm, [[Pulsatile Flow|pulsatile]]
*AV malformations: [[Thrill]], warm, [[Pulsatile Flow|pulsatile]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Grow proportionally with age
*Grow proportionally with age
Line 170: Line 150:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Doppler ultrasound]]: Venous malformations show slow flow, hypoechoic, AV malformations show high flow
*[[Doppler ultrasound]]: Venous malformations show slow flow, hypoechoic, AV malformations show high flow
*[[MRI]] with Gd: Diffuse enhancement
*[[MRI]] with Gd: Diffuse enhancement
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 181: Line 160:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Age]]: Birth - 5yrs
*[[Age]]: Birth - 5yrs
*Sex: No predilection
*Sex: No predilection
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 189: Line 167:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Soft
*Soft
*Non-compressible
*Non-compressible
*Non-pulsatile
*Non-pulsatile
*Fluctuant
*Fluctuant
*[[Transillumination]]+
*[[Transillumination]]+
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Never regress, expand/contract based on [[inflammation]]
*Never regress, expand/contract based on [[inflammation]]
Line 203: Line 176:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Dilated [[lymphatic]] channels lined by [[endothelial cells]]
*Dilated [[lymphatic]] channels lined by [[endothelial cells]]
*Positive D2-40 stain
*Positive D2-40 stain
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 218: Line 190:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*More common in adults
*More common in adults
*[[Male]]: [[female]] = 5:1
*[[Male]]: [[female]] = 5:1
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Presents with a neck [[swelling]], [[hoarseness]], [[stridor]] and [[globus sensation]]
*Presents with a neck [[swelling]], [[hoarseness]], [[stridor]] and [[globus sensation]]
*Episodic in nature
*Episodic in nature
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 228: Line 198:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Soft
*Soft
*Reducible
*Reducible
*Increase in size on [[valsalva]]
*Increase in size on [[valsalva]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Common in glass blowers, trumpet players
*Common in glass blowers, trumpet players
Line 240: Line 207:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[X-ray]], [[CT]]: [[Fluid]] and [[air]] containing [[cystic]] masses
*[[X-ray]], [[CT]]: [[Fluid]] and [[air]] containing [[cystic]] masses
*[[CT]] is the preferred one
*[[CT]] is the preferred one
*Direct [[laryngoscopy]]
*Direct [[laryngoscopy]]
Line 252: Line 218:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Age]]: 1st and 2nd decade
*[[Age]]: 1st and 2nd decade
*[[Female]]: [[male]]=1:1.4
*[[Female]]: [[male]]=1:1.4
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 260: Line 225:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Well circumscribed
*Well circumscribed
*Fluctuant
*Fluctuant
*Soft
*Soft
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 276: Line 239:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Incidence]]: 1:4000 births
*[[Incidence]]: 1:4000 births
*Sex: No predilection
*Sex: No predilection
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 284: Line 246:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Firm
*Firm
*Non-tender
*Non-tender
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 302: Line 262:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Incidence]]: 3 per 10000 population
*[[Incidence]]: 3 per 10000 population
*[[Age]]: birth - 5 yrs
*[[Age]]: birth - 5 yrs
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 310: Line 269:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Freely mobile
*Freely mobile
*Solitary
*Solitary
*Rubbery
*Rubbery
*Nonpulsatile
*Nonpulsatile
*Noncompressible
*Noncompressible
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Usually normal/sometimes a pit or [[sinus]] is seen
*Usually normal/sometimes a pit or [[sinus]] is seen
*A tuft of [[hair]] at the center of the pit for [[nasal]] [[Dermoid cyst|dermoid]] [[cyst]]
*A tuft of [[hair]] at the center of the pit for [[nasal]] [[Dermoid cyst|dermoid]] [[cyst]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Keratinizing [[squamous epithelium]]
*Keratinizing [[squamous epithelium]]
*Occasional remnants of [[hair follicles]], [[adipose tissue]], and [[sweat glands]]
*Occasional remnants of [[hair follicles]], [[adipose tissue]], and [[sweat glands]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Ultrasound]]: Thin walled, unilocular
*[[Ultrasound]]: Thin walled, unilocular
*[[CT-scans|CT]]: With contrast well circumscribed, unilocular, sac-of-marbles appearance due to fatty tissue
*[[CT-scans|CT]]: With contrast well circumscribed, unilocular, sac-of-marbles appearance due to fatty tissue
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 340: Line 291:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Age]]: 1-10 yrs
*[[Age]]: 1-10 yrs
*[[Males]]>[[Females]]
*[[Males]]>[[Females]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 348: Line 298:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Soft
*Soft
*Compressible
*Compressible
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Squamous epithelium|Squamou]]<nowiki/>s/[[cuboidal epithelium]]
*[[Squamous epithelium|Squamou]]<nowiki/>s/[[cuboidal epithelium]]
*[[Lymphoid tissue]] in the [[cyst]] wall contains hassall corpuscles
*[[Lymphoid tissue]] in the [[cyst]] wall contains hassall corpuscles
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Ultrasound|Ultrasoun]]<nowiki/>d: Unilocular [[cystic]] [[mass]]
*[[Ultrasound|Ultrasoun]]<nowiki/>d: Unilocular [[cystic]] [[mass]]
*[[CT-scans|CT]]: Uni/multilocular, well circumscribed and nonenhancing
*[[CT-scans|CT]]: Uni/multilocular, well circumscribed and nonenhancing
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 388: Line 334:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Presents with an unilateral [[erythematous]] [[swelling]]
*Presents with an unilateral [[erythematous]] [[swelling]]
*[[Bad breath]]
*[[Bad breath]]
*[[Fever]] with [[chills]]
*[[Fever]] with [[chills]]
Line 395: Line 340:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Tenderness|Tender]]
*[[Tenderness|Tender]]
*Firm
*Firm
*[[Purulent]] [[discharge]] expressed from the [[duct]]
*[[Purulent]] [[discharge]] expressed from the [[duct]]
*Smooth
*Smooth
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Redness
*Redness
Line 406: Line 348:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*↑ [[ESR]]
*↑ [[ESR]]
*[[Leukocytosis]]
*[[Leukocytosis]]
| align="center" style="background:#F5F5F5;" |[[Inflammatory]] infiltrate with microabscess formation
| align="center" style="background:#F5F5F5;" |[[Inflammatory]] infiltrate with microabscess formation
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Ultrasound]]: Hypoechoic with ductal dilatation
*[[Ultrasound]]: Hypoechoic with ductal dilatation
*[[CT-scans|CT]]: Diffuse [[homogeneous]] enlargement
*[[CT-scans|CT]]: Diffuse [[homogeneous]] enlargement
| align="center" style="background:#F5F5F5;" |[[CT scan]]
| align="center" style="background:#F5F5F5;" |[[CT scan]]
Line 429: Line 369:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Non-tender
*Non-tender
*Firm
*Firm
*Smooth
*Smooth
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Mostly due to [[obstruction]] by a stone or [[stricture]]
*Mostly due to [[obstruction]] by a stone or [[stricture]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*↑ [[ESR]]
*↑ [[ESR]]
*[[Leukocytosis]]
*[[Leukocytosis]]
| align="center" style="background:#F5F5F5;" |[[Hyperplastic]] [[lymphoid]] infiltrates with loss of [[salivary gland]] acini
| align="center" style="background:#F5F5F5;" |[[Hyperplastic]] [[lymphoid]] infiltrates with loss of [[salivary gland]] acini
Line 453: Line 389:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Age]]: 10-35 yrs mainly
*[[Age]]: 10-35 yrs mainly
*Sex: No predilection
*Sex: No predilection
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 462: Line 397:
*Non-tender
*Non-tender
*Soft
*Soft
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Generalized/cervical lymphadenopathy
*Generalized/cervical lymphadenopathy
Line 468: Line 402:
↑[[SGOT]]/[[SGPT]]
↑[[SGOT]]/[[SGPT]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*H&E stain: Typical owl-eye inclusions(nuclear)
*H&E stain: Typical owl-eye inclusions (nuclear)
 
*[[Basophilic]] [[cytoplasmic]] inclusions
*[[Basophilic]] [[cytoplasmic]] inclusions
| align="center" style="background:#F5F5F5;" |Usually not necessary
| align="center" style="background:#F5F5F5;" |Usually not necessary
Line 481: Line 414:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Age]]: Mainly adolescents
*[[Age]]: Mainly adolescents
*Sex: No predilection
*Sex: No predilection
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Sore throat]]
*[[Sore throat]]
*[[Fever]]
*[[Fever]]
*[[Malaise]]
*[[Malaise]]
*[[Lymphadenopathy]]
*[[Lymphadenopathy]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 499: Line 428:
*B/L [[posterior]] [[cervical]], [[Axillary|axillar]]<nowiki/>y, [[inguinal]] lymphadenopathy
*B/L [[posterior]] [[cervical]], [[Axillary|axillar]]<nowiki/>y, [[inguinal]] lymphadenopathy
**[[Ulcer]]/[[rash]]
**[[Ulcer]]/[[rash]]
**[[Redness]]   
**[[Redness]]   
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Atypical [[lymphocytosis|lymphocytosi]]<nowiki/>[[lymphocytosis|s]]
*Atypical [[lymphocytosis|lymphocytosi]]<nowiki/>[[lymphocytosis|s]]
*+ Monospot test
*+ Monospot test
*[[IgM]] & [[IgG]] [[antibodies]] against VCA [[Epstein Barr virus|EBV]]
*[[IgM]] & [[IgG]] [[antibodies]] against VCA [[Epstein Barr virus|EBV]]
*↑↑[[SGOT]]/[[SGPT]]
*↑↑[[SGOT]]/[[SGPT]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[CD8+ T cells|CD8]]+ [[lymphocytes]]
*[[CD8+ T cells|CD8]]+ [[lymphocytes]]
*[[Tissue]] [[necrosis]]
*[[Tissue]] [[necrosis]]
*[[B lymphocytes|B lymphocyte]] blasts
*[[B lymphocytes|B lymphocyte]] blasts
| align="center" style="background:#F5F5F5;" |Usually not necessary
| align="center" style="background:#F5F5F5;" |Usually not necessary
Line 525: Line 449:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Flu]]-like illness
*[[Flu]]-like illness
*[[Rash]]
*[[Rash]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 532: Line 455:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Generalized lymphadenopathy
*Generalized lymphadenopathy
| align="center" style="background:#F5F5F5;" |[[Leukopenia|CD4+ Tcells]]
| align="center" style="background:#F5F5F5;" |
[[Thrombocytopenia]]
*[[Leukopenia]]
 
*[[Thrombocytopenia]]
[[Anemia]]
*[[Anemia]]
 
*Elevated [[AST]]/[[ALT]]
[[AST]]/[[ALT]]
*Elevated [[CRP]]
 
*Elevated [[ESR]]
[[CRP]]
 
[[ESR]]
| align="center" style="background:#F5F5F5;" |Lymphoid hyperplasia
| align="center" style="background:#F5F5F5;" |Lymphoid hyperplasia
| align="center" style="background:#F5F5F5;" |Usually not necessary
| align="center" style="background:#F5F5F5;" |Usually not necessary
Line 554: Line 474:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Sore throat]]
*[[Sore throat]]
*[[Cough]]
*[[Cough]]
*[[Runny nose]]
*[[Runny nose]]
*[[Sneezing]]
*[[Sneezing]]
Line 567: Line 485:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Lymphocytosis]]
*[[Lymphocytosis]]
*↑[[ESR]] & [[C-reactive protein (CRP)|C-reactive protein]]
*↑[[ESR]] & [[C-reactive protein (CRP)|C-reactive protein]]
| align="center" style="background:#F5F5F5;" |Inflammatory infiltrate
| align="center" style="background:#F5F5F5;" |Inflammatory infiltrate
Line 582: Line 499:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Age]]: Affects all age groups
*[[Age]]: Affects all age groups
*Sex: No predilection
*Sex: No predilection
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Fever]]
*[[Fever]]
*[[Chills]]
*[[Chills]]
*[[Swelling]]
*[[Swelling]]
*[[Joint pains]]
*[[Joint pains]]
Line 595: Line 509:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Tenderness|Tender]]
*[[Tenderness|Tender]]
*Edematous
*Edematous
| align="center" style="background:#F5F5F5;" |−
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*↑[[ESR]]
*↑[[ESR]]
*↑[[C-reactive protein (CRP)|C-reactive protein]]
*↑[[C-reactive protein (CRP)|C-reactive protein]]
*Regional lymphadenopathy
*Regional lymphadenopathy
Line 615: Line 528:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Incidence]]: 100-200 cases anually in USA
*[[Incidence]]: 100-200 cases anually in USA
*Sex: [[Males]]>[[females]]
*Sex: [[Males]]>[[females]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 640: Line 552:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Cat exposure
* Cat exposure
* [[Fever]]
* [[Fever]]
* [[Fatigue]]
* [[Fatigue]]
* [[Headache]]
* [[Headache]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
Line 652: Line 561:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Vesicular]]
* [[Vesicular]]
* [[Erythema]]   
* [[Erythema]]   
* [[Papule]] at site of inoculation
* [[Papule]] at site of inoculation
Line 666: Line 574:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Bacillary angiomatosis|Bacillary]] [[Angiomatosis]]
* [[Bacillary angiomatosis|Bacillary]] [[Angiomatosis]]
* [[Bacillary angiomatosis|Bacillary]] Peliosis
* [[Bacillary angiomatosis|Bacillary]] Peliosis
|-
|-
Line 674: Line 581:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* No predilection in [[race]], [[age]]
* No predilection in [[race]], [[age]]
 
* [[Male] to [[female]] ratio : 1.5 to 3:1
* [[Male]] to [[female]] ratio : 1.5 to 3:1
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* History of [[dental]] [[procedure]] or [[trauma]]
* History of [[dental]] [[procedure]] or [[trauma]]
* Poor [[oral]] [[hygiene]]
* Poor [[oral]] [[hygiene]]
* [[Swelling]] [[mandible]]
* [[Swelling]] [[mandible]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 686: Line 590:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Tender at the beginning   
* Tender at the beginning   
* [[Painless]]
* [[Painless]]
* Fluctuant
* Fluctuant
* Non-tender at late stage
* Non-tender at late stage
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Red
* Red
* Blue
* Blue
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* ↑ [[ESR]]
* ↑ [[ESR]]
* ↑ [[CRP]]
* ↑ [[CRP]]
[[Gram stain|Gram stains]]:
[[Gram stain|Gram stains]]:
Line 704: Line 603:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Sulfur|Sulfur granules]]
* [[Sulfur|Sulfur granules]]
* [[Filamentous]] [[organism]]
* [[Filamentous]] [[organism]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Histological]] [[examination]]
* [[Histological]] [[examination]]
* [[Bacterial]] [[culture]] of the [[abscess]]
* [[Bacterial]] [[culture]] of the [[abscess]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 721: Line 618:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Recent travel to [[endemic]] regions
* Recent travel to [[endemic]] regions
* Exposure to [[Tuberculosis|TB]] [[patients]]
* Exposure to [[Tuberculosis|TB]] [[patients]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 727: Line 623:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Matted [[cervical]]  [[Lymph node|nodes]]
* Matted [[cervical]]  [[Lymph node|nodes]]
* Firm
* Firm
* Non-tender
* Non-tender
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 741: Line 635:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Ultrasound|Neck Ultrasound]]: Multiple [[lymph nodes]]
* [[Ultrasound|Neck Ultrasound]]: Multiple [[lymph nodes]]
* Fusion tendency
* Fusion tendency
* Internal echoes
* Internal echoes
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Mycobacteria|Culture for mycobacteria]]
* [[Mycobacteria|Culture for mycobacteria]]
Line 757: Line 648:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Fever]]
* [[Fever]]
* Absence of [[cough]]
* Absence of [[cough]]
* Difficulty [[swallowing]]
* Difficulty [[swallowing]]
* [[Swelling|Swollen]] [[pharynx]]
* [[Swelling|Swollen]] [[pharynx]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
Line 774: Line 662:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Follicular [[hyperplasia]]
* Follicular [[hyperplasia]]
* [[Infiltration (medical)|Infiltration]] of [[Polymorphonuclear cells|polymorphonuclear]] [[cells]]
* [[Infiltration (medical)|Infiltration]] of [[Polymorphonuclear cells|polymorphonuclear]] [[cells]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 781: Line 668:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Acute rheumatic fever]]
* [[Acute rheumatic fever]]
* [[Glomerulonephritis|Post-streptoccocal glomerulonephritis]]
* [[Glomerulonephritis|Post-streptoccocal glomerulonephritis]]
|-
|-
Line 790: Line 676:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* 6 years old and older adults are more affected in U.S.
* 6 years old and older adults are more affected in U.S.
* Seen in Hot climates
* Seen in Hot climates
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Cat-scratch|Cats]] or birds [[feces]] exposure
* [[Cat-scratch|Cats]] or birds [[feces]] exposure
* Drinking [[unpasteurized milk]]
* Drinking [[unpasteurized milk]]
* Undercooked food
* Undercooked food
* [[Organ (anatomy)|Organ]] [[Organ transplant|transplant]] recipients
* [[Organ (anatomy)|Organ]] [[Organ transplant|transplant]] recipients
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
Line 804: Line 686:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Bilateral
* Bilateral
* Non-tender
* Non-tender
* Symmetrical
* Symmetrical
* Non-fluctuant
* Non-fluctuant
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 821: Line 700:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Serology]]
* [[Serology]]
* [[Immunofluorescence]]
* [[Immunofluorescence]]
[[MRI]]
[[MRI]]
Line 835: Line 713:
* [[Family]] history of [[sarcoidosis]]
* [[Family]] history of [[sarcoidosis]]
* [[Fatigue]]
* [[Fatigue]]
* [[Swelling]] and [[pain]] in the [[joints]]
* [[Swelling]] and [[pain]] in the [[joints]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 843: Line 720:
tender [[lymph nodes]]
tender [[lymph nodes]]
* [[Swelling|Swollen]]
* [[Swelling|Swollen]]
* Non-tender [[parotid glands]]
* Non-tender [[parotid glands]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Erythema nodosum]]
* [[Erythema nodosum]]
* [[Lupus]] pernios
* [[Lupus]] pernios
* Lymphadenopathy
* Lymphadenopathy
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* ↑ [[ESR]]
* ↑ [[ESR]]
* ↑ [[Angiotensin-converting enzyme|ACE]]
* ↑ [[Angiotensin-converting enzyme|ACE]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 858: Line 732:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[CXR]]: B/L [[hilar]] [[adenopathy]]
* [[CXR]]: B/L [[hilar]] [[adenopathy]]
* [[MRI]]: B/L multiples enlarged [[cervical lymph nodes]]
* [[MRI]]: B/L multiples enlarged [[cervical lymph nodes]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Biopsy]]
* [[Biopsy]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Heerfordt's syndrome: [[uveitis]], facial nerve paralysis, [[parotitis]]
* Heerfordt's syndrome: [[uveitis]], facial nerve paralysis, [[parotitis]]
|-
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |[[Sjögren's syndrome|Sjögren syndrome]]<ref name="pmid24566651">{{cite journal |vauthors=Mavragani CP, Moutsopoulos HM |title=Sjögren syndrome |journal=CMAJ |volume=186 |issue=15 |pages=E579–86 |date=October 2014 |pmid=24566651 |pmc=4203623 |doi=10.1503/cmaj.122037 |url=}}</ref>
! colspan="2" align="center" style="background:#DCDCDC;" |[[Sjögren's syndrome|Sjögren syndrome]]<ref name="pmid24566651">{{cite journal |vauthors=Mavragani CP, Moutsopoulos HM |title=Sjögren syndrome |journal=CMAJ |volume=186 |issue=15 |pages=E579–86 |date=October 2014 |pmid=24566651 |pmc=4203623 |doi=10.1503/cmaj.122037 |url=}}</ref>
Line 873: Line 743:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Female]] to [[male]] ratio: 9 to 1
* [[Female]] to [[male]] ratio: 9 to 1
* May happen at any [[age]]
* May happen at any [[age]]
* Mean age: 40-50
* Mean age: 40-50
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* History of [[RA]], [[SLE]], and non-hodgkin B-cell lymphoma.
* History of [[RA]], [[SLE]], and non-hodgkin B-cell lymphoma.
 
* Dry [[mouth]], dry [[eyes]]
* Dry [[mouth]], dry [[eyes]].
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Firm,
* Firm,
* B/L enlarged [[parotid glands]]
* B/L enlarged [[parotid glands]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Pruritis]]
* [[Pruritis]]
* [[Rashes]]
* [[Rashes]]
* Dry
* Dry
* Lymphadenopathy
* Lymphadenopathy
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[ESR|↑ ESR]]
* [[ESR|↑ ESR]]
* Anti-SSA/Ro: +
* Anti-SSA/Ro: +
* Anti-SSB/La: +
* Anti-SSB/La: +
* [[Cytopenia]]
* [[Cytopenia]]
* Wetting <5 mm on [[Schirmer's test]]
* Wetting <5 mm on [[Schirmer's test]]
Line 916: Line 778:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Asymptomatic]] at early onset
* [[Asymptomatic]] at early onset
* B-symptoms
* B-symptoms
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 951: Line 812:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* High [[prevalence]] in Japan
* High [[prevalence]] in Japan
* More common in young adults <30 years old
* More common in young adults <30 years old
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Fever]]
* [[Fever]]
* [[Flu]]-like prodrome
* [[Flu]]-like prodrome
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
Line 966: Line 825:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* ↑ [[ESR]]
* ↑ [[ESR]]
* [[Liver enzymes|Abnormal liver enzymes]]
* [[Liver enzymes|Abnormal liver enzymes]]
* [[leucopenia]]
* [[leucopenia]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Irregular paracortical areas of [[coagulative]] [[necrosis]] with abundant karyorrhectic debris
* Irregular paracortical areas of [[coagulative]] [[necrosis]] with abundant karyorrhectic debris
Line 990: Line 846:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Large
* Large
* Non-tender [[Cervical|cervical node]]
* Non-tender [[Cervical|cervical node]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 998: Line 853:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Conserved [[Lymph nodes|lymph node]] structure
* Conserved [[Lymph nodes|lymph node]] structure
* [[Eosinophilic]] [[Infiltration (medical)|infiltration]]
* [[Eosinophilic]] [[Infiltration (medical)|infiltration]]
* High [[Capillary|postcapillary]] [[venules]]
* High [[Capillary|postcapillary]] [[venules]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 1,008: Line 860:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Nephrotic syndrome]]
* [[Nephrotic syndrome]]
* [[Hypercoagulable state]]
* [[Hypercoagulable state]]
|-
|-
Line 1,018: Line 869:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Fever]]
* [[Fever]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 1,028: Line 878:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* ↑ [[ESR]]
* ↑ [[ESR]]
* [[Polyclonal]] [[hypergammaglobulinemia]]
* [[Polyclonal]] [[hypergammaglobulinemia]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 1,040: Line 889:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* More common in children younger than 5 years old.
* More common in children younger than 5 years old.
* Highest [[incidence]] in Japan.
* Highest [[incidence]] in Japan.
* Most leading cause of acquired [[heart disease]] in U.S.
* Most leading cause of acquired [[heart disease]] in U.S.
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* High [[fever]]
* High [[fever]]
* B/L [[conjunctivitis]]
* B/L [[conjunctivitis]]
* [[Rash]]
* [[Rash]]
* [[Swelling]] of hands and feet
* [[Swelling]] of hands and feet
* Inflammation of [[lips]]
* Inflammation of [[lips]]
* [[Strawberry tongue]]
* [[Strawberry tongue]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 1,065: Line 905:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* ↑ [[ESR]]
* ↑ [[ESR]]
* ↑ [[CRP]]
* ↑ [[CRP]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 1,073: Line 912:
[[dilation]]
[[dilation]]
* [[Coronary artery]] [[aneurysm]]
* [[Coronary artery]] [[aneurysm]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Clinical|Clinical findings]]
* [[Clinical|Clinical findings]]
Line 1,124: Line 962:
* [[Soft tissue]] mass
* [[Soft tissue]] mass
* Irregular thickening of [[mucosa]]
* Irregular thickening of [[mucosa]]
* [[Necrotic|Necrotic region]]
* [[Necrotic|Necrotic region]]
[[MRI]]:  
[[MRI]]:  
Line 1,138: Line 975:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* More common in Females
* More common in Females
 
* [[Incidence]] increase with [[age]]
* [[Incidence]] increase with [[age]].
 
* [[Incidence]] : 2-3.5 cases per 100,000 [[population]]
* [[Incidence]] : 2-3.5 cases per 100,000 [[population]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* History of [[swelling]]
* History of [[swelling]]
* [[Dysphagia]]
* [[Dysphagia]]
* [[Hoarseness]]
* [[Hoarseness]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 1,153: Line 985:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Palpable [[mass]] of deep [[lobe]] of [[parotid gland]]
* Palpable [[mass]] of deep [[lobe]] of [[parotid gland]]
* Firm
* Firm
* Mobile
* Mobile
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 1,163: Line 993:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[MRI]]:<ref name="pmid29845358">{{cite journal |vauthors=Kato H, Kawaguchi M, Ando T, Mizuta K, Aoki M, Matsuo M |title=Pleomorphic adenoma of salivary glands: common and uncommon CT and MR imaging features |journal=Jpn J Radiol |volume=36 |issue=8 |pages=463–471 |date=August 2018 |pmid=29845358 |doi=10.1007/s11604-018-0747-y |url=}}</ref> Homogenous on T1
* [[MRI]]:<ref name="pmid29845358">{{cite journal |vauthors=Kato H, Kawaguchi M, Ando T, Mizuta K, Aoki M, Matsuo M |title=Pleomorphic adenoma of salivary glands: common and uncommon CT and MR imaging features |journal=Jpn J Radiol |volume=36 |issue=8 |pages=463–471 |date=August 2018 |pmid=29845358 |doi=10.1007/s11604-018-0747-y |url=}}</ref> Homogenous on T1
* Abundant myxochondroid [[stroma]] on T2
* Abundant myxochondroid [[stroma]] on T2
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 1,174: Line 1,003:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Male]] to [[Female]] ratio : 4:1
* [[Male]] to [[Female]] ratio : 4:1
* More common in people aged 60 to 70 years old.
* More common in people aged 60 to 70 years old.
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* History of [[Swelling|swollen]] [[salivary gland]]
* History of [[Swelling|swollen]] [[salivary gland]]
* [[Jaw]] pain
* [[Jaw]] pain
* [[Tinnitus]]
* [[Tinnitus]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Non tender
* Non tender
* Mobile
* Mobile
* Firm
* Firm
* [[Solitary]]
* [[Solitary]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 1,197: Line 1,019:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Papillae]]
* [[Papillae]]
* [[Fibrous]] [[capsule]]
* [[Fibrous]] [[capsule]]
* [[Cystic]] spaces
* [[Cystic]] spaces
| align="center" style="background:#F5F5F5;" | [[CT|Neck CT]]:  
| align="center" style="background:#F5F5F5;" | [[CT|Neck CT]]:  
Line 1,219: Line 1,039:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Growing [[palpable]] painless mass
*Growing [[palpable]] painless mass
*[[Facial swelling]]
*[[Facial swelling]]
*[[Lymphadenopathy]] (if transformed to malignant)
*[[Lymphadenopathy]] (if transformed to malignant)
Line 1,227: Line 1,046:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Normal
*Normal
*Redness
*Redness
*[[Swelling]]
*[[Swelling]]
Line 1,233: Line 1,051:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Normal
*Normal
*[[Anemia]]
*[[Anemia]]
| align="center" style="background:#F5F5F5;" |[[Epithelial cells]] with [[eosinophilic]] granular [[cytoplasm]] rich in [[mitochondria]]
| align="center" style="background:#F5F5F5;" |[[Epithelial cells]] with [[eosinophilic]] granular [[cytoplasm]] rich in [[mitochondria]]
Line 1,253: Line 1,070:
*Age: From 26 to 76 years
*Age: From 26 to 76 years
*Rare in children
*Rare in children
*Sex: No sex predilection
*Sex: No sex predilection
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Growing [[palpable]] painless [[mass]] on jaw or in [[oral cavity]]
*Growing [[palpable]] painless [[mass]] on jaw or in [[oral cavity]]
*[[Facial swelling]]
*[[Facial swelling]]
*[[Lymphadenopathy]] (if transformed to [[malignant]])
*[[Lymphadenopathy]] (if transformed to [[malignant]])
Line 1,267: Line 1,082:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Normal
*Normal
*Redness
*Redness
*Skin [[ulceration]]
*Skin [[ulceration]]
Line 1,293: Line 1,107:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Age::  Mean age of 59
*Age::  Mean age of 59
 
*Female predilection
*Gender: Female predilection
*
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Painlesss [[mass]]
*Painlesss [[mass]]
Line 1,332: Line 1,144:
| align="center" style="background:#F5F5F5;" |[[Gross]] findings: Tubular, cribriform and solid pattern of growth
| align="center" style="background:#F5F5F5;" |[[Gross]] findings: Tubular, cribriform and solid pattern of growth
[[Microscopic]] findings: Components of large cells with [[Pleomorphic|pleomorphic nuclei]]
[[Microscopic]] findings: Components of large cells with [[Pleomorphic|pleomorphic nuclei]]
increased mitotic activity, and focal [[Necrosis|necrosis.]]
increased mitotic activity, and focal [[Necrosis|necrosis.]]
| align="center" style="background:#F5F5F5;" |[[Imaging]] reveal dimensions of the [[tumor]], local spread and [[Metastasis|distant metastasis]]
| align="center" style="background:#F5F5F5;" |[[Imaging]] reveal dimensions of the [[tumor]], local spread and [[Metastasis|distant metastasis]]
Line 1,362: Line 1,173:
| align="center" style="background:#F5F5F5;" |[[Incidence]]: 1% to 3%
| align="center" style="background:#F5F5F5;" |[[Incidence]]: 1% to 3%
Gender: Men
Gender: Men
Mean age: 55 to 61 years
Mean age: 55 to 61 years
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 1,370: Line 1,180:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Painless, hard and non-compressible [[mass]]
*Painless, hard and non-compressible [[mass]]
*In case of facial nerve involvement may present with [[facial paralysis]]
*In case of facial nerve involvement may present with [[facial paralysis]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 1,393: Line 1,202:
| align="center" style="background:#F5F5F5;" |Incidence: rare [[tumor]]
| align="center" style="background:#F5F5F5;" |Incidence: rare [[tumor]]
Age: Old age , 61 to 68 years
Age: Old age , 61 to 68 years
 
Male predilection
Gender: Male predilection
| align="center" style="background:#F5F5F5;" |Present as painful growing [[mass]] on [[jaw]]
| align="center" style="background:#F5F5F5;" |Present as painful growing [[mass]] on [[jaw]]
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
Line 1,407: Line 1,215:
| align="center" style="background:#F5F5F5;" |[[Gross]] findings: Shows skin tissue and thinning of [[skin]]
| align="center" style="background:#F5F5F5;" |[[Gross]] findings: Shows skin tissue and thinning of [[skin]]
[[Microscopically]] findings:
[[Microscopically]] findings:
Nest and solid sheets of [[Tumor cell|tumor cells]] arranged in [[glandular]] pattern. It is derived from epidermoid cells of [[salivary gland]].
Nest and solid sheets of [[Tumor cell|tumor cells]] arranged in [[glandular]] pattern. It is derived from epidermoid cells of [[salivary gland]].
May show [[vascular]] [[invasion]] and [[inflammatory]] infiltrate.
May show [[vascular]] [[invasion]] and [[inflammatory]] infiltrate.
[[Immunohistochemical staining]] can be used to mark the [[squamous]] and [[keratin]] component.
[[Immunohistochemical staining]] can be used to mark the [[squamous]] and [[keratin]] component.
| align="center" style="background:#F5F5F5;" |[[Tumor]] dimension can be delineated using both [[CT]] and [[MRI]]
| align="center" style="background:#F5F5F5;" |[[Tumor]] dimension can be delineated using both [[CT]] and [[MRI]]
Line 1,422: Line 1,227:
| align="center" style="background:#F5F5F5;" |[[Incidence]]: Rare
| align="center" style="background:#F5F5F5;" |[[Incidence]]: Rare
Mean age : 44 to 54 years
Mean age : 44 to 54 years
Gender: Female predilection
Gender: Female predilection
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 1,431: Line 1,235:
*[[Fatigue]]
*[[Fatigue]]
*[[Confusion]]
*[[Confusion]]
*
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
Line 1,459: Line 1,262:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*A slow growing  [[Neck masses|neck mass]]
*A slow growing  [[Neck masses|neck mass]]
*
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*Mobile non-tender [[Neck masses|neck mass]] (horizontally more than vertically)
*Mobile non-tender [[Neck masses|neck mass]] (horizontally more than vertically)
*
*[[Pulsatile Flow|Pulsatile]]  
*[[Pulsatile Flow|Pulsatile]]  
*[[Bruit]] may be present
*[[Bruit]] may be present
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 1,478: Line 1,277:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
*[[Doppler ultrasound]], [[Computed tomography|CT,]] [[MRI]] and [[angiography]] is used to visualize the [[tumor]].
*[[Doppler ultrasound]], [[Computed tomography|CT,]] [[MRI]] and [[angiography]] is used to visualize the [[tumor]].
*[[Metaiodobenzylguanidine|Metaiodobenzylguanidine (MIBG)]] testing
*[[Metaiodobenzylguanidine|Metaiodobenzylguanidine (MIBG)]] testing
| align="center" style="background:#F5F5F5;" |[[Histopathology]] analysis and [[catecholamine]] levels
| align="center" style="background:#F5F5F5;" |[[Histopathology]] analysis and [[catecholamine]] levels
Line 1,496: Line 1,294:
*[[Headache]]
*[[Headache]]
*Change in voice Vertigo
*Change in voice Vertigo
[[Catecholamine]]<nowiki/>secreting [[paragangliomas]] present with :
[[Catecholamine]] secreting [[paragangliomas]] present with :
 
*[[Hypertension]]
*[[Hypertension]]
*[[Headache]]
*[[Headache]]
Line 1,510: Line 1,307:
[[Gross examination|Gross]] findings:
[[Gross examination|Gross]] findings:
*Fleshy [[tumor]]<nowiki/>s
*Fleshy [[tumor]]<nowiki/>s
 
*Pink to red-brown to gray in color
*Pink to red brown to gray in color
 
*Associated with [[hemorrhage]] or [[fibrosis]]
*Associated with [[hemorrhage]] or [[fibrosis]]
[[Microscopic|Microscopic findings]]:
[[Microscopic|Microscopic findings]]:
Round or polygonal cells arranged inside capsule in the form of nests or  forming trabecular structures.
Round or polygonal cells arranged inside capsule in the form of nests or  forming trabecular structures.
Differentiation between [[benign]] or [[malignancy]] form is done depending  [[microscopic]] features of [[invasion]] and [[Mitotic index|high mitotic index]]
Differentiation between [[benign]] or [[malignancy]] form is done depending  [[microscopic]] features of [[invasion]] and [[Mitotic index|high mitotic index]]
| align="center" style="background:#F5F5F5;" |Following imaging techniques can be used to diagnose the [[tumor]]:
| align="center" style="background:#F5F5F5;" |Following imaging techniques can be used to diagnose the [[tumor]]:
*[[Ultrasound]]
*[[Ultrasound]]
*[[Computed tomography]]
*[[Computed tomography]]
*[[Magnetic resonance imaging]]
*[[Magnetic resonance imaging]]
As these are secretory tumors further testing with following techniques can confirm [[diagnose]]<nowiki/>s:
As these are secretory tumors further testing with following techniques can confirm [[diagnose]]<nowiki/>s:
*[[Angiography]]
*[[Angiography]]
*[[metaiodobenzylguanidine]] (MIBG)
*[[metaiodobenzylguanidine]] (MIBG)
Line 1,536: Line 1,327:
| align="center" style="background:#F5F5F5;" |[[Benign]]
| align="center" style="background:#F5F5F5;" |[[Benign]]
| align="center" style="background:#F5F5F5;" |Rare [[tumor]]
| align="center" style="background:#F5F5F5;" |Rare [[tumor]]
Incidence: 1% to 10%
Incidence: 1% to 10%
| align="center" style="background:#F5F5F5;" |Slow growing [[mass]] presents with the localized neural deficit depending on the site of [[peripheral nerve]] involved.
| align="center" style="background:#F5F5F5;" |Slow growing [[mass]] presents with the localized neural deficit depending on the site of [[peripheral nerve]] involved.
[[Vagal]] involvement:
[[Vagal]] involvement:
* [[Hoarseness]]  
* [[Hoarseness]]  
Line 1,553: Line 1,342:
| align="center" style="background:#F5F5F5;" |Multiple slow growing  [[nodules]] on the skin
| align="center" style="background:#F5F5F5;" |Multiple slow growing  [[nodules]] on the skin
| align="center" style="background:#F5F5F5;" |Associated with [[neurofibromatosis type II]].
| align="center" style="background:#F5F5F5;" |Associated with [[neurofibromatosis type II]].
Most common nerve involved in [[vestibular nerve]]
Most common nerve involved in [[vestibular nerve]]
| align="center" style="background:#F5F5F5;" |May be normal
| align="center" style="background:#F5F5F5;" |May be normal
Line 1,565: Line 1,353:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |[[Lymphoma]] <ref name="pmid7139563">{{cite journal |vauthors=Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT |title=Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute |journal=Cancer |volume=50 |issue=12 |pages=2699–707 |date=December 1982 |pmid=7139563 |doi= |url=}}</ref><ref name="pmid71395632">{{cite journal |vauthors=Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT |title=Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute |journal=Cancer |volume=50 |issue=12 |pages=2699–707 |date=December 1982 |pmid=7139563 |doi= |url=}}</ref>
! colspan="2" align="center" style="background:#DCDCDC;" |[[Lymphoma]] <ref name="pmid7139563">{{cite journal |vauthors=Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT |title=Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute |journal=Cancer |volume=50 |issue=12 |pages=2699–707 |date=December 1982 |pmid=7139563 |doi= |url=}}</ref><ref name="pmid71395632">{{cite journal |vauthors=Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT |title=Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute |journal=Cancer |volume=50 |issue=12 |pages=2699–707 |date=December 1982 |pmid=7139563 |doi= |url=}}</ref>
<ref name="pmid15185336">{{cite journal |vauthors=Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S |title=B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review |journal=Int. J. Cancer |volume=111 |issue=1 |pages=1–8 |date=August 2004 |pmid=15185336 |doi=10.1002/ijc.20205 |url=}}</ref><ref name="pmid2406917">{{cite journal |vauthors=Moormeier JA, Williams SF, Golomb HM |title=The staging of non-Hodgkin's lymphomas |journal=Semin. Oncol. |volume=17 |issue=1 |pages=43–50 |date=February 1990 |pmid=2406917 |doi= |url=}}</ref><ref name="pmid151853362">{{cite journal |vauthors=Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S |title=B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review |journal=Int. J. Cancer |volume=111 |issue=1 |pages=1–8 |date=August 2004 |pmid=15185336 |doi=10.1002/ijc.20205 |url=}}</ref><ref name="pmid71395633">{{cite journal |vauthors=Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT |title=Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute |journal=Cancer |volume=50 |issue=12 |pages=2699–707 |date=December 1982 |pmid=7139563 |doi= |url=}}</ref>
<ref name="pmid15185336">{{cite journal |vauthors=Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S |title=B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review |journal=Int. J. Cancer |volume=111 |issue=1 |pages=1–8 |date=August 2004 |pmid=15185336 |doi=10.1002/ijc.20205 |url=}}</ref><ref name="pmid2406917">{{cite journal |vauthors=Moormeier JA, Williams SF, Golomb HM |title=The staging of non-Hodgkin's lymphomas |journal=Semin. Oncol. |volume=17 |issue=1 |pages=43–50 |date=February 1990 |pmid=2406917 |doi= |url=}}</ref><ref name="pmid151853362">{{cite journal |vauthors=Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S |title=B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review |journal=Int. J. Cancer |volume=111 |issue=1 |pages=1–8 |date=August 2004 |pmid=15185336 |doi=10.1002/ijc.20205 |url=}}</ref><ref name="pmid71395633">{{cite journal |vauthors=Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT |title=Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute |journal=Cancer |volume=50 |issue=12 |pages=2699–707 |date=December 1982 |pmid=7139563 |doi= |url=}}</ref>
| align="center" style="background:#F5F5F5;" |[[Benign]]/ [[malignant]]
| align="center" style="background:#F5F5F5;" |[[Benign]]/ [[malignant]]
| align="center" style="background:#F5F5F5;" |Age: Predilection for older age
| align="center" style="background:#F5F5F5;" |Age: Predilection for older age
Mean age: 55
Mean age: 55
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Insidious onset slow growing [[Lymph node|lymph nodes]] with non-specific systemic [[B symptoms]] ([[fever]], [[night sweats]], [[weight loss]])
* Insidious onset slow growing [[Lymph node|lymph nodes]] with non-specific systemic [[B symptoms]] ([[fever]], [[night sweats]], [[weight loss]])
* [[Rash]]
* [[Rash]]
* Waxing and waning [[lymphadenopathy]]  
* Waxing and waning [[lymphadenopathy]]  
* [[Abdominal fullness]] [[hepatomegaly]]  and [[splenomegaly]]
* [[Abdominal fullness]] [[hepatomegaly]]  and [[splenomegaly]]
Line 1,584: Line 1,367:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Multiple chain [[lymphadenopathy]]
* Multiple chain [[lymphadenopathy]]
* [[Hepatomegaly]]
* [[Hepatomegaly]]
* [[Splenomegaly]]
* [[Splenomegaly]]
Line 1,596: Line 1,378:
* [[Anemia]]
* [[Anemia]]
* [[Thrombocytopenia]]
* [[Thrombocytopenia]]
* [[Leukopenia]]
* [[Leukopenia]]
* [[Hypercalcemia]]
* [[Hypercalcemia]]
* [[Hyperuricemia]]       (increased cell turnover)
* [[Hyperuricemia]] (increased cell turnover)
* [[Immunoglobulin|Monoclonal immunoglobulin]] (M-spike)
* [[Immunoglobulin|Monoclonal immunoglobulin]] (M-spike)
* Raised [[LDH]] levels
* Raised [[LDH]] levels
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Fine needle aspiration]] (FNA) with cytometry is used for screening.
* [[Fine needle aspiration]] (FNA) with cytometry is used for screening.
* Tissue [[biopsy]] is used for diagnose.
* Tissue [[biopsy]] is used for diagnose.
* On complete node analysis four patterns are described:
* On complete node analysis four patterns are described:
Line 1,617: Line 1,397:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |[[Liposarcoma]] <ref name="pmid171979142">{{cite journal |vauthors=Evans HL |title=Atypical lipomatous tumor, its variants, and its combined forms: a study of 61 cases, with a minimum follow-up of 10 years |journal=Am. J. Surg. Pathol. |volume=31 |issue=1 |pages=1–14 |date=January 2007 |pmid=17197914 |doi=10.1097/01.pas.0000213406.95440.7a |url=}}</ref><ref name="pmid21253554">{{cite journal |vauthors=Conyers R, Young S, Thomas DM |title=Liposarcoma: molecular genetics and therapeutics |journal=Sarcoma |volume=2011 |issue= |pages=483154 |date=2011 |pmid=21253554 |pmc=3021868 |doi=10.1155/2011/483154 |url=}}</ref>
! colspan="2" align="center" style="background:#DCDCDC;" |[[Liposarcoma]] <ref name="pmid171979142">{{cite journal |vauthors=Evans HL |title=Atypical lipomatous tumor, its variants, and its combined forms: a study of 61 cases, with a minimum follow-up of 10 years |journal=Am. J. Surg. Pathol. |volume=31 |issue=1 |pages=1–14 |date=January 2007 |pmid=17197914 |doi=10.1097/01.pas.0000213406.95440.7a |url=}}</ref><ref name="pmid21253554">{{cite journal |vauthors=Conyers R, Young S, Thomas DM |title=Liposarcoma: molecular genetics and therapeutics |journal=Sarcoma |volume=2011 |issue= |pages=483154 |date=2011 |pmid=21253554 |pmc=3021868 |doi=10.1155/2011/483154 |url=}}</ref><ref name="pmid19194281">{{cite journal |vauthors=Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Oliveira AM, Folpe AL |title=Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age |journal=Am. J. Surg. Pathol. |volume=33 |issue=5 |pages=645–58 |date=May 2009 |pmid=19194281 |doi=10.1097/PAS.0b013e3181963c9c |url=}}</ref><ref name="pmid176106862">{{cite journal |vauthors=Serpell JW, Chen RY |title=Review of large deep lipomatous tumours |journal=ANZ J Surg |volume=77 |issue=7 |pages=524–9 |date=July 2007 |pmid=17610686 |doi=10.1111/j.1445-2197.2007.04042.x |url=}}</ref>
 
<ref name="pmid19194281">{{cite journal |vauthors=Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Oliveira AM, Folpe AL |title=Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age |journal=Am. J. Surg. Pathol. |volume=33 |issue=5 |pages=645–58 |date=May 2009 |pmid=19194281 |doi=10.1097/PAS.0b013e3181963c9c |url=}}</ref><ref name="pmid176106862">{{cite journal |vauthors=Serpell JW, Chen RY |title=Review of large deep lipomatous tumours |journal=ANZ J Surg |volume=77 |issue=7 |pages=524–9 |date=July 2007 |pmid=17610686 |doi=10.1111/j.1445-2197.2007.04042.x |url=}}</ref>
| align="center" style="background:#F5F5F5;" |[[Malignant]]
| align="center" style="background:#F5F5F5;" |[[Malignant]]
| align="center" style="background:#F5F5F5;" |Rare [[tumors]]
| align="center" style="background:#F5F5F5;" |Rare [[tumors]]
Age: Relatively in older age
Age: Relatively in older age
Gender: No gender predilection
Gender: No gender predilection
| align="center" style="background:#F5F5F5;" |Mobile [[Mass|masses]] with very few symptoms until  they grow enough to compress the surrounding structures, which produces symptoms of neural deficit, pain, tingling or skin changes.
| align="center" style="background:#F5F5F5;" |Mobile [[Mass|masses]] with very few symptoms until  they grow enough to compress the surrounding structures, which produces symptoms of neural deficit, pain, tingling or skin changes.
| align="center" style="background:#F5F5F5;" | ±
| align="center" style="background:#F5F5F5;" | ±
Line 1,636: Line 1,411:
| align="center" style="background:#F5F5F5;" |[[Gross examination|Gross]] findings:
| align="center" style="background:#F5F5F5;" |[[Gross examination|Gross]] findings:
Bulk of yellow colored fat tissue.
Bulk of yellow colored fat tissue.
[[Microscopic|Microscopic features]]:
[[Microscopic|Microscopic features]]:
[[Adipose tissue]] containing that containing lipoblasts atypical [[nucleus]] pushed to side by intracytoplasmic vacuoles.
[[Adipose tissue]] containing that containing lipoblasts atypical [[nucleus]] pushed to side by intracytoplasmic vacuoles.
Tissue biopsy may show [[histological]] sub-groups:
Tissue biopsy may show [[histological]] sub-groups:
* Well-differentiated
* Well-differentiated
Line 1,646: Line 1,418:
* Pleomorphic liposarcomas
* Pleomorphic liposarcomas
| align="center" style="background:#F5F5F5;" | [[Imaging]] is not usually used for diagnoses except to look for deeper [[invasion]].
| align="center" style="background:#F5F5F5;" | [[Imaging]] is not usually used for diagnoses except to look for deeper [[invasion]].
[[Ultrasound]] shows homogeneous hyperechoic [[mass]].
[[Ultrasound]] shows homogeneous hyperechoic [[mass]].
| align="center" style="background:#F5F5F5;" | [[Biopsy]] and [[Histopathology|histopathology analysis]]
| align="center" style="background:#F5F5F5;" | [[Biopsy]] and [[Histopathology|histopathology analysis]]
Line 1,657: Line 1,428:
* Unspecific gender or age association
* Unspecific gender or age association
| align="center" style="background:#F5F5F5;" |One or multiple soft, painless skin nodules.
| align="center" style="background:#F5F5F5;" |One or multiple soft, painless skin nodules.
May causes pain or compressive [[symptoms]]
May causes pain or compressive [[symptoms]]
| align="center" style="background:#F5F5F5;" | ±
| align="center" style="background:#F5F5F5;" | ±
Line 1,666: Line 1,436:
| align="center" style="background:#F5F5F5;" |Normal
| align="center" style="background:#F5F5F5;" |Normal
| align="center" style="background:#F5F5F5;" |Diagnoses is usually [[clinical]] but tissue [[biopsy]] may show  
| align="center" style="background:#F5F5F5;" |Diagnoses is usually [[clinical]] but tissue [[biopsy]] may show  
Bundle of well-demarcated lipocytes with single [[nuclei]] aligned to the side and intra-cytoplasimic fat granules.
Bundle of well-demarcated lipocytes with single [[nuclei]] aligned to the side and intra-cytoplasimic fat granules.
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
Diagnoses is usually clinical but [[ultrasound]] is used to differentiate [[lipoma]] from other [[benign]] lesions such as [[epidermoid cyst]] or a [[ganglion]].
Diagnoses is usually clinical but [[ultrasound]] is used to differentiate [[lipoma]] from other [[benign]] lesions such as [[epidermoid cyst]] or a [[ganglion]].
| align="center" style="background:#F5F5F5;" | [[Clinical]] evaluation
| align="center" style="background:#F5F5F5;" | [[Clinical]] evaluation
and tissue [[biopsy]]
and tissue [[biopsy]]
| align="center" style="background:#F5F5F5;" | Multiple [[lipomas]] are associated with [[familial]] multiple lipomatosis
| align="center" style="background:#F5F5F5;" | Multiple [[lipomas]] are associated with [[familial]] multiple lipomatosis
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Glomus vagale, [[Glomus jugulare tumor|glomus jugulare]] tumors
! colspan="2" align="center" style="background:#DCDCDC;" |Glomus vagale, [[Glomus jugulare tumor|glomus jugulare]] tumors
 
<ref name="pmid8164483">{{cite journal |vauthors=Urquhart AC, Johnson JT, Myers EN, Schechter GL |title=Glomus vagale: paraganglioma of the vagus nerve |journal=Laryngoscope |volume=104 |issue=4 |pages=440–5 |date=April 1994 |pmid=8164483 |doi=10.1288/00005537-199404000-00008 |url=}}</ref><ref name="pmid6308990">{{cite journal |vauthors=Valavanis A, Schubiger O, Oguz M |title=High-resolution CT investigation of nonchromaffin paragangliomas of the temporal bone |journal=AJNR Am J Neuroradiol |volume=4 |issue=3 |pages=516–9 |date=1983 |pmid=6308990 |doi= |url=}}</ref><ref name="pmid81644832">{{cite journal |vauthors=Urquhart AC, Johnson JT, Myers EN, Schechter GL |title=Glomus vagale: paraganglioma of the vagus nerve |journal=Laryngoscope |volume=104 |issue=4 |pages=440–5 |date=April 1994 |pmid=8164483 |doi=10.1288/00005537-199404000-00008 |url=}}</ref><ref name="pmid1988766">{{cite journal |vauthors=Stein PP, Black HR |title=A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience |journal=Medicine (Baltimore) |volume=70 |issue=1 |pages=46–66 |date=January 1991 |pmid=1988766 |doi= |url=}}</ref><ref name="pmid17400487">{{cite journal |vauthors=Sajid MS, Hamilton G, Baker DM |title=A multicenter review of carotid body tumour management |journal=Eur J Vasc Endovasc Surg |volume=34 |issue=2 |pages=127–30 |date=August 2007 |pmid=17400487 |doi=10.1016/j.ejvs.2007.01.015 |url=}}</ref><ref name="pmid15883711">{{cite journal |vauthors=Boedeker CC, Ridder GJ, Schipper J |title=Paragangliomas of the head and neck: diagnosis and treatment |journal=Fam. Cancer |volume=4 |issue=1 |pages=55–9 |date=2005 |pmid=15883711 |doi=10.1007/s10689-004-2154-z |url=}}</ref>
<ref name="pmid8164483">{{cite journal |vauthors=Urquhart AC, Johnson JT, Myers EN, Schechter GL |title=Glomus vagale: paraganglioma of the vagus nerve |journal=Laryngoscope |volume=104 |issue=4 |pages=440–5 |date=April 1994 |pmid=8164483 |doi=10.1288/00005537-199404000-00008 |url=}}</ref><ref name="pmid6308990">{{cite journal |vauthors=Valavanis A, Schubiger O, Oguz M |title=High-resolution CT investigation of nonchromaffin paragangliomas of the temporal bone |journal=AJNR Am J Neuroradiol |volume=4 |issue=3 |pages=516–9 |date=1983 |pmid=6308990 |doi= |url=}}</ref><ref name="pmid81644832">{{cite journal |vauthors=Urquhart AC, Johnson JT, Myers EN, Schechter GL |title=Glomus vagale: paraganglioma of the vagus nerve |journal=Laryngoscope |volume=104 |issue=4 |pages=440–5 |date=April 1994 |pmid=8164483 |doi=10.1288/00005537-199404000-00008 |url=}}</ref><ref name="pmid1988766">{{cite journal |vauthors=Stein PP, Black HR |title=A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience |journal=Medicine (Baltimore) |volume=70 |issue=1 |pages=46–66 |date=January 1991 |pmid=1988766 |doi= |url=}}</ref>
 
<ref name="pmid17400487">{{cite journal |vauthors=Sajid MS, Hamilton G, Baker DM |title=A multicenter review of carotid body tumour management |journal=Eur J Vasc Endovasc Surg |volume=34 |issue=2 |pages=127–30 |date=August 2007 |pmid=17400487 |doi=10.1016/j.ejvs.2007.01.015 |url=}}</ref><ref name="pmid15883711">{{cite journal |vauthors=Boedeker CC, Ridder GJ, Schipper J |title=Paragangliomas of the head and neck: diagnosis and treatment |journal=Fam. Cancer |volume=4 |issue=1 |pages=55–9 |date=2005 |pmid=15883711 |doi=10.1007/s10689-004-2154-z |url=}}</ref>
| align="center" style="background:#F5F5F5;" |[[Benign]]
| align="center" style="background:#F5F5F5;" |[[Benign]]
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Rare tumor
Rare tumor
*
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Painless slowly enlarging [[Mass|mass in the neck]]
* Painless slowly enlarging [[Mass|mass in the neck]]
Line 1,702: Line 1,465:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Glomus tumor|Glomus tumors]] arise from Non [[Chromaffin cells]] their [[histopathology]] reveals "salt and pepper" [[chromatin]] which is typical of tumor.
* [[Glomus tumor|Glomus tumors]] arise from Non [[Chromaffin cells]] their [[histopathology]] reveals "salt and pepper" [[chromatin]] which is typical of tumor.
* On [[immunohistochemistry]] [[Tumor cell|tumor]] cells show [[chromogranin]]  and [[S-100]] positivisty
* On [[immunohistochemistry]] [[Tumor cell|tumor]] cells show [[chromogranin]]  and [[S-100]] positivisty
*
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Imaging]] is important for the diagnosis.
* [[Imaging]] is important for the diagnosis.
* [[Imaging]] of  choice is [[MRI]].
* [[Imaging]] of  choice is [[MRI]].
* [[MRI]] may show typical appearance of the [[tumor]] along [[Vagus nerve]].
* [[MRI]] may show typical appearance of the [[tumor]] along [[Vagus nerve]].
Line 1,724: Line 1,483:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Asymptomatic
* Asymptomatic
* Painless [[lymphadenopathy]].
* Painless [[lymphadenopathy]]
 
* Supra clavicular fullness in case of [[stomach cancer]] [[metastasis]]
* Supra clavicular fullness in case of [[stomach cancer]] [[metastasis]]
| align="center" style="background:#F5F5F5;" | −
| align="center" style="background:#F5F5F5;" | −
Line 1,744: Line 1,502:
* Older males
* Older males
* Younger patients with [[Human papillomavirus|HPV]] infection or smoking history
* Younger patients with [[Human papillomavirus|HPV]] infection or smoking history
*
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Neck masses|Neck mass]]
* [[Neck masses|Neck mass]]
Line 1,755: Line 1,512:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Examination of [[neck]] and [[oral cavity]] may show [[mass]] and [[lymphadenopathy]].
* Examination of [[neck]] and [[oral cavity]] may show [[mass]] and [[lymphadenopathy]].
* Examination of [[laryngeal cancer]] is done using flexible [[laryngoscopy]] under [[anesthesia]].
* Examination of [[laryngeal cancer]] is done using flexible [[laryngoscopy]] under [[anesthesia]].
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 1,764: Line 1,520:
| align="center" style="background:#F5F5F5;" |[[Human papillomavirus|HPV testing]] may show [[HPV infection]]
| align="center" style="background:#F5F5F5;" |[[Human papillomavirus|HPV testing]] may show [[HPV infection]]
| align="center" style="background:#F5F5F5;" |[[FNA]] of [[Neck masses|neck mass]] followed by [[biopsy]] is done to diagnose [[laryngeal cancer]]. It  show type cancerous cells.
| align="center" style="background:#F5F5F5;" |[[FNA]] of [[Neck masses|neck mass]] followed by [[biopsy]] is done to diagnose [[laryngeal cancer]]. It  show type cancerous cells.
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* [[Computed tomography|CT]], [[Magnetic resonance imaging|MRI]] and [[Positron emission tomography|PET]] are used to see local infiltration by [[cancer]] and also distant [[metastases]].
* [[Computed tomography|CT]], [[Magnetic resonance imaging|MRI]] and [[Positron emission tomography|PET]] are used to see local infiltration by [[cancer]] and also distant [[metastases]].
* Panendoscopy is done to see extent of the [[tumor]].
* Panendoscopy is done to see extent of the [[tumor]].
| align="center" style="background:#F5F5F5;" | [[Laryngoscopy]] and [[biopsy]]
| align="center" style="background:#F5F5F5;" | [[Laryngoscopy]] and [[biopsy]]
Line 1,778: Line 1,532:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Expanding [[Neck masses|neck mass]]
* Expanding [[Neck masses|neck mass]]
* [[Headaches]]
* [[Headaches]]
* [[Dizziness]]
* [[Dizziness]]
* [[Neurological|Neurological sequels]]
* [[Neurological|Neurological sequels]]
Line 1,787: Line 1,539:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Pulsating [[Neck masses|neck mass]]
* Pulsating [[Neck masses|neck mass]]
* [[Bruit]]
* [[Bruit]]
| align="center" style="background:#F5F5F5;" |May be associated with [[vasculopathies]] and [[metastatic]] invasion of vessels and neck surgery
| align="center" style="background:#F5F5F5;" |May be associated with [[vasculopathies]] and [[metastatic]] invasion of vessels and neck surgery
Line 1,801: Line 1,552:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Female predominance
* Female predominance
* Young age (benign causes)
* Young age (benign causes)
* Old age ([[malignant]] etiology)
* Old age ([[malignant]] etiology)
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Growing painless [[Neck masses|neck mass]] in front of neck
* Growing painless [[Neck masses|neck mass]] in front of neck
* [[Weight loss]]
* [[Weight loss]]
* Palpitation  
* Palpitation  
* [[Hoarseness]]
* [[Hoarseness]]
* [[Irritability]]
* [[Irritability]]
| align="center" style="background:#F5F5F5;" | ±
| align="center" style="background:#F5F5F5;" | ±
| align="center" style="background:#F5F5F5;" | ±
| align="center" style="background:#F5F5F5;" | ±
Line 1,824: Line 1,569:
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
* Normal to low [[TSH|TSH levels]] in case of malignancy
* Normal to low [[TSH|TSH levels]] in case of malignancy
* High TSH levels in case of [[goiter]]
* High TSH levels in case of [[goiter]]
| align="center" style="background:#F5F5F5;" |[[FNA]] is done in case of [[goiter]] and [[Biopsy|core biopsy]] is performed if [[malignancy]] is suspected
| align="center" style="background:#F5F5F5;" |[[FNA]] is done in case of [[goiter]] and [[Biopsy|core biopsy]] is performed if [[malignancy]] is suspected
| align="center" style="background:#F5F5F5;" | [[Ultrasonography|USG]]: Shows nodular or non- nodular lesions in [[Thyroid]]. [[Ultrasonography|US]] is better than [[Computed tomography|CT]].
| align="center" style="background:#F5F5F5;" | [[Ultrasonography|USG]]: Shows nodular or non- nodular lesions in [[Thyroid]]. [[Ultrasonography|US]] is better than [[Computed tomography|CT]].
[[Thyroid]] [[radionuclide imaging]]: Shows [[radioiodine]] uptake and is usually cold in case of [[malignancy]] and may be cold or hot in case of [[goiter]].
[[Thyroid]] [[radionuclide imaging]]: Shows [[radioiodine]] uptake and is usually cold in case of [[malignancy]] and may be cold or hot in case of [[goiter]].
| align="center" style="background:#F5F5F5;" | [[Biopsy]] and [[histopathology]] of nodules
| align="center" style="background:#F5F5F5;" | [[Biopsy]] and [[histopathology]] of nodules

Revision as of 17:32, 15 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Neck masses must be differentiated from congenital abnormalities, inflammatory, and malignant lesions.

Differentiating neck masses from other Diseases

Neck masses must be differentiated from congenital abnormalities, inflammatory, and malignant lesions.

Category Diseases Benign/

Malignant

Clinical manifestation Paraclinical findings Gold standard diagnosis Associated findings
Demography History Symptoms Signs Lab findings Histopathology Imaging
Pain Dysphagia Mass exam Others
Congenital Branchial cleft cyst[1]
  • Age: 1-15 years old
  • Familial occurrence
  • Lateral neck mass
±
  • Solitary
  • Smooth
  • Mobile
  • Well-defined
  • Non-pulsatile
  • Fluctuant
  • A pit at the opening of the cyst
Thyroglossal duct cyst[2][3]
  • Age: 1-10 yrs/ varies
  • Mobile
Haemangioma[4]
  • Presents with a flat red or purple patch
  • Regress gradually with age
  • Firm
  • Rubbery
  • Well-demarcated
  • Ultrasound: High flow with vascular channels
  • MRI: With or without Gd is the modality of choice
Vascular malformations[5][6]
  • Incidence: 1 in 2000 to 5000 births
  • Sex: No predilection
±
  • Grow proportionally with age
  • Doppler ultrasound: Venous malformations show slow flow, hypoechoic, AV malformations show high flow
  • MRI with Gd: Diffuse enhancement
  • MRI
Lymphatic malformations[7][8]
  • Age: Birth - 5yrs
  • Sex: No predilection
+
  • Ultrasound: Hypo/anechoic with thick septa and fluid
  • CT: Homogeneous and cystic mass
  • MRI: Hyperintense on T2 & peripheral wall enhancement on T1
Laryngocele[9][10][11] +
  • Soft
  • Reducible
  • Increase in size on valsalva
  • Common in glass blowers, trumpet players
Ranula[12][13]
  • Well circumscribed
  • Fluctuant
  • Soft
H&E: Shows mucin surrounded by inflammatory cells & fibrosis CT: Shows cystic mass with tail sign
Teratoma[14][15]
  • Incidence: 1:4000 births
  • Sex: No predilection
  • Firm
  • Non-tender
  • High ALP levels
  • Shows ecto, meso and endodermal tissues
Dermoid cyst[16][17]
  • Freely mobile
  • Solitary
  • Rubbery
  • Nonpulsatile
  • Noncompressible
  • Ultrasound: Thin walled, unilocular
  • CT: With contrast well circumscribed, unilocular, sac-of-marbles appearance due to fatty tissue
Thymic cyst[18]
  • Presents as a soft mass, gradually enlarging, on left side of the neck(usual)
  • Soft
  • Compressible
Category Diseases Benign Demography History Pain Dysphagia Mass exam Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings
Inflammatory Acute sialadenitis [19]
  • Age:Occurs in all age groups
  • Sex: No predilection
+ - Inflammatory infiltrate with microabscess formation CT scan
Chronic sialadenitis[20]
  • Age:Occurs in all age groups
  • Sex: No predilection
  • Presents with an unilateral swelling
  • Recurrent episodes common
+ -
  • Non-tender
  • Firm
  • Smooth
Hyperplastic lymphoid infiltrates with loss of salivary gland acini

Fibrosis

X-ray: Shows radiopaque stones

CT: Parenchymal volume is ↓

CT scan
Reactive viral lymphadenopathy CMV[21]
  • Age: 10-35 yrs mainly
  • Sex: No predilection
  • Flu-like illness
  • Non-tender
  • Soft
  • Generalized/cervical lymphadenopathy
ESR

SGOT/SGPT

Usually not necessary
EBV[22][23]
  • Age: Mainly adolescents
  • Sex: No predilection
  • Non-tender
  • Firm
Usually not necessary
HIV[24] Benign Prevalence: 1.1 million in U.S

Sex: Males>females

Non-tender
  • Generalized lymphadenopathy
Lymphoid hyperplasia Usually not necessary Western blot & P24 antigen assay
Viral URI [25] Incidence: More in fall & winter

Age: Common in elderly and infants

  • Non-tender
  • Mild cervical lymphadenopathy
Inflammatory infiltrate
  • No specific findings
-
Bacterial lymphadenopathy Tularemia[26][27]
  • Age: Affects all age groups
  • Sex: No predilection
+
  • No specific findings
Brucellosis[28]
  • Flu-like illness
+
  • Cervical lymphadenopathy
ESR
  • No specific findings
Serology
Cat-scratch disease[29][30]
  • More common in the Southern of U.S among children and young adults.
+

Serology:

- -
Actinomycosis[31][32]
  • No predilection in race, age
  • [[Male] to female ratio : 1.5 to 3:1
  • Tender at the beginning
  • Painless
  • Fluctuant
  • Non-tender at late stage
  • Red
  • Blue

Gram stains:

Mycobacterial infections[22][33][34]
  • Lymphadenopathy

Sputum smear:

Streptococcal infection[21][35] + +
  • Lymphadenopathy
Parasitic lymphadenopathy Toxoplasma gondii[36][37]
  • 6 years old and older adults are more affected in U.S.
  • Seen in Hot climates
+
  • Bilateral
  • Non-tender
  • Symmetrical
  • Non-fluctuant
  • Lymphadenopathy

+ IgG and IgM antibodies

MRI:

MRI

Sarcoidosis[38][19]
  • More common in African American women aged 20 - 40 years.
  • Bilateral

tender lymph nodes

Sjögren syndrome[39]
  • Female to male ratio: 9 to 1
  • May happen at any age
  • Mean age: 40-50
  • History of RA, SLE, and non-hodgkin B-cell lymphoma.
  • Dry mouth, dry eyes
+
Castleman disease (angiofollicular lymphoproliferative disease)[40][41] Mean age: 30-40 years
  • Lymphadenopathy
CT scan of thorax
Kikuchi disease (histiocytic necrotizing lymphadenitis)[42]
  • High prevalence in Japan
  • More common in young adults <30 years old
+
  • Skin rash
  • Lymphadenopathy
Kimura disease[43]
  • More common in Asian males.
Eosinophils
Rosai-Dorfman disease[44][45]
Kawasaki disease[46][47]
  • More common in children younger than 5 years old.
  • Highest incidence in Japan.
  • Most leading cause of acquired heart disease in U.S.
Echocardiography:

dilation

Category Diseases Benign or Malignant Demography History Pain Dysphagia Mass exam Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings
Neoplasm Hypopharyngeal cancer[48][49][50]
  • More common in males
  • Age: 55-65 years old
  • Incidence: < 1/100,000 in U.S.
  • More common: Japan, India, Iran
+ Neck CT scan:

MRI:

  • Tumors are hypointense on T1 and hyperintense on T2
Salivary gland neoplasm Pleomorphic adenoma[51] +
Warthin's tumor[53][54]
  • Male to Female ratio : 4:1
  • More common in people aged 60 to 70 years old.
+ Neck CT:

MRI:

  • B/L lesions

Heterogeneous

Oncocytoma

[55]

Benign
  • Race: Caucasian patients predilection
  • Gender: No gender preference
  • Age: 50–70 years
± ± Firm, multilobulated and mobile mass Epithelial cells with eosinophilic granular cytoplasm rich in mitochondria
  • CT:
    • Isodense expansive mass
    • Enhancement after intravenous contrast
    • Hypodense areas
  • MRI:
    • Isodensties on T1
    • Mass is hyperintense on T2
    • Enhancement on contrast
Incisional biopsy and histopathological examination
Monomorphic adenoma [56][57][58] Benign or malignant
  • Age: From 26 to 76 years
  • Rare in children
  • Sex: No sex predilection
± ± Nodular and fluctuant swelling
  • Normal
  • Redness
  • Skin ulceration
  • May have lymphadenopathy
Normal Ultrasound:
  • Used to biopsy the lesion
  • May show cystic an solid components

CT:

MRI:

Incisional biopsy and histopathological examination
Mucoepidermoid carcinoma

[59]

Malignant
  • Age:: Mean age of 59
  • Female predilection
± ± Cystic and solid mass
  • May have lymphadenopathy
Gross findings:
  • Firm
  • Tan-white to yellow
  • Bosselated
  • Cystic

Microscopic findings:

cystic and solid component with variable appearance Incisional biopsy and histopathological examination Association with CMV
Adenoid cystic carcinoma [60] Malignant Age: 40s to 60s

Gender: Female predominance

± ± Solid mass Gross findings: Tubular, cribriform and solid pattern of growth

Microscopic findings: Components of large cells with pleomorphic nuclei increased mitotic activity, and focal necrosis.

Imaging reveal dimensions of the tumor, local spread and distant metastasis Biopsy and histopathological examination
Adenocarcinoma

[61]

Malignant Age: young age predilection Its a tumor of minor salivary glands so may present as small ulceration or nodules in oral cavity Small nodules and oral cavity with or without lymphadenopathy Can be normal or may show anemia and blood cell disorders with distant bone invasion On histology it is confused with Adeocyctic carcinoma with components of gland and cyst formations.

It has more perineural invasion.

CT and MRI both can be used to visualize the tumor. MRI being more accurate for adjacent tissue involvement and lymphadenopathy. Biopsy and histopathological examination
Salivary duct cancer

[62][63][64]

Malignant

(Highly aggressive)

Incidence: 1% to 3%

Gender: Men Mean age: 55 to 61 years

  • Rapidly growing mass with jaw involvement
± ±
  • Painless, hard and non-compressible mass
  • In case of facial nerve involvement may present with facial paralysis
Pathomorphologically tumor of salivary ducts resembles tumor of breast ducts, and that where it name is derived from Gross findings:

Microscopic finding:

  • Microscopically it resembles ductal carcinoma of breast
  • Intraductal components invading surrounding tissues
  • Intra-ductal component of tumor arrange in several forms: cribriform, papillary, solid with comedo-like central necrosis
Non-specific features on CT and MRI but it can show neural and jaw involvement. Biopsy and histopathological examination
Squamous cell carcinoma

[65][66]

Malignant Incidence: rare tumor

Age: Old age , 61 to 68 years Male predilection

Present as painful growing mass on jaw + Submandibular gland predilection

Thinning and discoloration of skin

Past radiation exposure is a strong risk factor Gross findings: Shows skin tissue and thinning of skin

Microscopically findings: Nest and solid sheets of tumor cells arranged in glandular pattern. It is derived from epidermoid cells of salivary gland. May show vascular invasion and inflammatory infiltrate. Immunohistochemical staining can be used to mark the squamous and keratin component.

Tumor dimension can be delineated using both CT and MRI Biopsy and histopathological examination
Parathyroid cancer

[67][68][69]

Malignant Incidence: Rare

Mean age : 44 to 54 years Gender: Female predilection

+ + Lower neck mass Microscopic findings:Tumor shows trabecular growth pattern with high mitosis and surrounding thick fibrous bands. Capsular involvement and vascular invasion is common Biopsy and histopathological examination
Carotid body tumors

[70][71][72][73]

Benign
  • Age: 26-55 years
  • Male predominance
+ May show Increased catecholamine levels Microscopically they are extra- adrenal paragangliomas Histopathology analysis and catecholamine levels
Paraganglioma

[74][75][76]

Benign (Majority)

Malignant (rare)

  • Age 50-70 years
  • More in females
May be an accidental finding depending on their secretory nature or present with following symptoms:

Catecholamine secreting paragangliomas present with :

No visible mass as they are located deep in the the neck along the glossopharyngeal and vagal nerves. Associated with some hereditary syndromes and MEN2B syndrome, Neurofibromatosis type 1 and VHL disease Biochemical testing may show catecholamine metabolites in serum or urine samples These are highly vascular tumors that involves nerves around vessels

Gross findings:

Microscopic findings: Round or polygonal cells arranged inside capsule in the form of nests or forming trabecular structures. Differentiation between benign or malignancy form is done depending microscopic features of invasion and high mitotic index

Following imaging techniques can be used to diagnose the tumor:

As these are secretory tumors further testing with following techniques can confirm diagnoses:

Imaging and serum catecholamine analysis
Schwannoma

[77][78][79]

Benign Rare tumor

Incidence: 1% to 10%

Slow growing mass presents with the localized neural deficit depending on the site of peripheral nerve involved.

Vagal involvement:

Sympathetic nerve involvement may present as Horner's syndrome:

Vestibular Schwannoma (most common):

+ ± Multiple slow growing nodules on the skin Associated with neurofibromatosis type II.

Most common nerve involved in vestibular nerve

May be normal

vagus nerve or superior cervical sympathetic chain being most common locations.

  • Histology shows encapsulated neural tissue growth.
Imaging can diagnose the tumor. Its hard to discriminate Carotid body tumor from Schwannoma on CT. MRI and MRI angiography can confirm the diagnoses. Imaging is used for diagnoses
Lymphoma [80][81]

[82][83][84][85]

Benign/ malignant Age: Predilection for older age

Mean age: 55

±
  • Fine needle aspiration (FNA) with cytometry is used for screening.
  • Tissue biopsy is used for diagnose.
  • On complete node analysis four patterns are described:
    • Nodular/follicular
    • Diffuse pattern
    • Transition from a nodular to a diffuse pattern in adjacent nodes
    • Transition from a lower to a higher grade of involvement within a single node
Lymph node biopsy coupled with cytometry
Liposarcoma [86][87][88][89] Malignant Rare tumors

Age: Relatively in older age Gender: No gender predilection

Mobile masses with very few symptoms until they grow enough to compress the surrounding structures, which produces symptoms of neural deficit, pain, tingling or skin changes. ± Mobile soft mass with intact overlying skin and in some cases with blue discoloration due to intra-lesion hemorrhage
  • Intact skin and normal color
Normal Gross findings:

Bulk of yellow colored fat tissue. Microscopic features: Adipose tissue containing that containing lipoblasts atypical nucleus pushed to side by intracytoplasmic vacuoles. Tissue biopsy may show histological sub-groups:

  • Well-differentiated
  • Myxoid/round cell
  • Pleomorphic liposarcomas
Imaging is not usually used for diagnoses except to look for deeper invasion.

Ultrasound shows homogeneous hyperechoic mass.

Biopsy and histopathology analysis
Lipoma [90][91][92] Benign One or multiple soft, painless skin nodules.

May causes pain or compressive symptoms

± Mobile soft nodule with intact overlying skin
  • Intact skin and normal color
Normal Diagnoses is usually clinical but tissue biopsy may show

Bundle of well-demarcated lipocytes with single nuclei aligned to the side and intra-cytoplasimic fat granules.

Diagnoses is usually clinical but ultrasound is used to differentiate lipoma from other benign lesions such as epidermoid cyst or a ganglion.

Clinical evaluation

and tissue biopsy

Multiple lipomas are associated with familial multiple lipomatosis
Glomus vagale, glomus jugulare tumors

[93][94][95][96][97][98]

Benign

Rare tumor

± Secretory tumors are diagnosed by biochemical testing using Metaiodobenzylguanidine (MIBG) , followed by imaging to locate the tumor Normal
  • Imaging is important for the diagnosis.
  • Imaging of choice is MRI.
  • MRI may show typical appearance of the tumor along Vagus nerve.
  • USG may used to see the tumor but it is for early stage of diagnoses.
  • US shows isoechoic to hypoechoic well defined tumor.
  • CT can show vascularity of tumor.
  • Biochemical testing to see secretary nature of tumor
Imaging and MIBG testing
Metastatic head and neck cancer

[99][100]

Malignant Depends on the nature of metastatic tumor ± Non-tender mass in the neck or non-tender lymphadenopathy Majority of metastatic head and neck cancer metastatise from GIT and lungs and are squamous cell caners Vary depending on the underlying cancer Histology of primary cancer CT and MRI shows extend of the tumor and other regions of metastasis Biopsy and histopathology of the primary site of tumor
Other Laryngeal cancer

[101][102]

Benign/Malignant
  • Older males
  • Younger patients with HPV infection or smoking history
± ±

human papillomavirus (HPV) infection

HPV testing may show HPV infection FNA of neck mass followed by biopsy is done to diagnose laryngeal cancer. It show type cancerous cells. Laryngoscopy and biopsy
Arteriovenous fistula

[103][104]

Benign/Malignant Depends on the risk factors May be associated with vasculopathies and metastatic invasion of vessels and neck surgery Varies depending on the etiology MR angiography may be used to visualize the tract MR angiography
Thyroid nodule/ Goiter

[105][106][107][108]

Benign/ Malignant
  • Female predominance
  • Young age (benign causes)
  • Old age (malignant etiology)
± ±
  • Painless non-tender and asymmetrical neck mass in front of neck with smooth overlying skin and nodular surface
  • Depending on the type may be mobile or adherent to the underlying structure
  • Lymphadenopathy in case of malignant features
Goiter is most commonly associated with iodine deficiency
  • Normal to low TSH levels in case of malignancy
  • High TSH levels in case of goiter
FNA is done in case of goiter and core biopsy is performed if malignancy is suspected USG: Shows nodular or non- nodular lesions in Thyroid. US is better than CT.

Thyroid radionuclide imaging: Shows radioiodine uptake and is usually cold in case of malignancy and may be cold or hot in case of goiter.

Biopsy and histopathology of nodules
Category Diseases Benign Demography History Pain Dysphagia Mass exam Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings

References

  1. Nahata, Vaishali (2016). "Branchial cleft cyst". Indian Journal of Dermatology. 61 (6): 701. doi:10.4103/0019-5154.193718. ISSN 0019-5154.
  2. Amos J, Shermetaro C. PMID 30085599. Missing or empty |title= (help)
  3. Deaver MJ, Silman EF, Lotfipour S (August 2009). "Infected thyroglossal duct cyst". West J Emerg Med. 10 (3): 205. PMC 2729228. PMID 19718389.
  4. Léauté-Labrèze, C.; Prey, S.; Ezzedine, K. (2011). "Infantile haemangioma: Part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities". Journal of the European Academy of Dermatology and Venereology. 25 (11): 1245–1253. doi:10.1111/j.1468-3083.2011.04102.x. ISSN 0926-9959.
  5. Cox JA, Bartlett E, Lee EI (May 2014). "Vascular malformations: a review". Semin Plast Surg. 28 (2): 58–63. doi:10.1055/s-0034-1376263. PMC 4078214. PMID 25045330.
  6. Behravesh S, Yakes W, Gupta N, Naidu S, Chong BW, Khademhosseini A, Oklu R (December 2016). "Venous malformations: clinical diagnosis and treatment". Cardiovasc Diagn Ther. 6 (6): 557–569. doi:10.21037/cdt.2016.11.10. PMC 5220204. PMID 28123976.
  7. Cox JA, Bartlett E, Lee EI (May 2014). "Vascular malformations: a review". Semin Plast Surg. 28 (2): 58–63. doi:10.1055/s-0034-1376263. PMC 4078214. PMID 25045330.
  8. Guruprasad Y, Chauhan DS (September 2012). "Cervical cystic hygroma". J Maxillofac Oral Surg. 11 (3): 333–6. doi:10.1007/s12663-010-0149-x. PMC 3428451. PMID 23997487.
  9. Werner RL, Schroeder JW, Castle JT (March 2014). "Bilateral laryngoceles". Head Neck Pathol. 8 (1): 110–3. doi:10.1007/s12105-013-0478-4. PMC 3950389. PMID 23881550.
  10. Prasad KC, Vijayalakshmi S, Prasad SC (December 2008). "Laryngoceles - presentations and management". Indian J Otolaryngol Head Neck Surg. 60 (4): 303–8. doi:10.1007/s12070-008-0108-8. PMC 3476818. PMID 23120570.
  11. Mahdoufi R, Barhmi I, Tazi N, Abada R, Roubal M, Mahtar M (July 2017). "Mixed Pyolaryngocele: A Rare Case of Deep Neck Infection". Iran J Otorhinolaryngol. 29 (93): 225–228. PMC 5554815. PMID 28819622.
  12. Packiri S, Gurunathan D, Selvarasu K (September 2017). "Management of Paediatric Oral Ranula: A Systematic Review". J Clin Diagn Res. 11 (9): ZE06–ZE09. doi:10.7860/JCDR/2017/28498.10622. PMC 5713871. PMID 29207849.
  13. Kokong D, Iduh A, Chukwu I, Mugu J, Nuhu S, Augustine S (June 2017). "Ranula: Current Concept of Pathophysiologic Basis and Surgical Management Options". World J Surg. 41 (6): 1476–1481. doi:10.1007/s00268-017-3901-2. PMC 5422487. PMID 28194490.
  14. Chauhan DS, Guruprasad Y, Inderchand S (September 2011). "Congenital nasopharyngeal teratoma with a cleft palate: case report and a 7 year follow up". J Maxillofac Oral Surg. 10 (3): 253–6. doi:10.1007/s12663-010-0140-6. PMC 3238564. PMID 22942597.
  15. Bahgat M, Bahgat Y, Bahgat A (July 2012). "Oropharyngeal teratoma, a rare cause of airway obstruction in neonates". BMJ Case Rep. 2012. doi:10.1136/bcr-2012-006580. PMC 4543570. PMID 22814615.
  16. Paradis, Josée; Koltai, Peter J. (2015). "Pediatric Teratoma and Dermoid Cysts". Otolaryngologic Clinics of North America. 48 (1): 121–136. doi:10.1016/j.otc.2014.09.009. ISSN 0030-6665.
  17. Gaddikeri S, Vattoth S, Gaddikeri RS, Stuart R, Harrison K, Young D, Bhargava P (2014). "Congenital cystic neck masses: embryology and imaging appearances, with clinicopathological correlation". Curr Probl Diagn Radiol. 43 (2): 55–67. doi:10.1067/j.cpradiol.2013.12.001. PMID 24629659.
  18. Gaddikeri, Santhosh; Vattoth, Surjith; Gaddikeri, Ramya S.; Stuart, Royal; Harrison, Keith; Young, Daniel; Bhargava, Puneet (2014). "Congenital Cystic Neck Masses: Embryology and Imaging Appearances, With Clinicopathological Correlation". Current Problems in Diagnostic Radiology. 43 (2): 55–67. doi:10.1067/j.cpradiol.2013.12.001. ISSN 0363-0188.
  19. 19.0 19.1 Abdel Razek A, Mukherji S (June 2017). "Imaging of sialadenitis". Neuroradiol J. 30 (3): 205–215. doi:10.1177/1971400916682752. PMC 5480791. PMID 28059621. Vancouver style error: initials (help)
  20. Orlandi MA, Pistorio V, Guerra PA (2013). "Ultrasound in sialadenitis". J Ultrasound. 16 (1): 3–9. doi:10.1007/s40477-013-0002-4. PMC 3774898. PMID 24046793.
  21. 21.0 21.1 Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (March 2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
  22. 22.0 22.1 Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (March 2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
  23. Stuhlmann-Laeisz C, Oschlies I, Klapper W (December 2014). "Detection of EBV in reactive and neoplastic lymphoproliferations in adults-when and how?". J Hematop. 7 (4): 165–170. doi:10.1007/s12308-014-0209-0. PMC 4243011. PMID 25478033.
  24. Moonim MT, Alarcon L, Freeman J, Mahadeva U, van der Walt JD, Lucas SB (March 2010). "Identifying HIV infection in diagnostic histopathology tissue samples--the role of HIV-1 p24 immunohistochemistry in identifying clinically unsuspected HIV infection: a 3-year analysis". Histopathology. 56 (4): 530–41. doi:10.1111/j.1365-2559.2010.03513.x. PMID 20459560.
  25. Thomas M, Bomar PA. PMID 30422556. Missing or empty |title= (help)
  26. Grunow R, Splettstoesser W, McDonald S, Otterbein C, O'Brien T, Morgan C, Aldrich J, Hofer E, Finke EJ, Meyer H (January 2000). "Detection of Francisella tularensis in biological specimens using a capture enzyme-linked immunosorbent assay, an immunochromatographic handheld assay, and a PCR". Clin. Diagn. Lab. Immunol. 7 (1): 86–90. PMC 95828. PMID 10618283.
  27. Koç, Sema (2012). "Clinical and laboratory findings of tularemia: a retrospective analysis". The Turkish Journal of Ear Nose and Throat: 26–31. doi:10.5606/kbbihtisas.2012.005. ISSN 1300-7475.
  28. Golshani M, Buozari S (November 2017). "A review of Brucellosis in Iran: Epidemiology, Risk Factors, Diagnosis, Control, and Prevention". Iran. Biomed. J. 21 (6): 349–59. PMC 5572431. PMID 28766326.
  29. "Cat-Scratch Disease in the United States, 2005–2013 - Volume 22, Number 10—October 2016 - Emerging Infectious Diseases journal - CDC".
  30. Hansmann, Y.; DeMartino, S.; Piemont, Y.; Meyer, N.; Mariet, P.; Heller, R.; Christmann, D.; Jaulhac, B. (2005). "Diagnosis of Cat Scratch Disease with Detection of Bartonella henselae by PCR: a Study of Patients with Lymph Node Enlargement". Journal of Clinical Microbiology. 43 (8): 3800–3806. doi:10.1128/JCM.43.8.3800-3806.2005. ISSN 0095-1137.
  31. Valour F, Sénéchal A, Dupieux C, Karsenty J, Lustig S, Breton P, Gleizal A, Boussel L, Laurent F, Braun E, Chidiac C, Ader F, Ferry T (2014). "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management". Infect Drug Resist. 7: 183–97. doi:10.2147/IDR.S39601. PMC 4094581. PMID 25045274.
  32. Bonnefond S, Catroux M, Melenotte C, Karkowski L, Rolland L, Trouillier S, Raffray L (June 2016). "Clinical features of actinomycosis: A retrospective, multicenter study of 28 cases of miscellaneous presentations". Medicine (Baltimore). 95 (24): e3923. doi:10.1097/MD.0000000000003923. PMC 4998488. PMID 27311002.
  33. Suskind DL, Handler SD, Tom LW, Potsic WP, Wetmore RF (July 1997). "Nontuberculous mycobacterial cervical adenitis". Clin Pediatr (Phila). 36 (7): 403–9. doi:10.1177/000992289703600705. PMID 9241478.
  34. Drobniewski FA, Caws M, Gibson A, Young D (March 2003). "Modern laboratory diagnosis of tuberculosis". Lancet Infect Dis. 3 (3): 141–7. PMID 12614730.
  35. Kenealy T (November 2007). "Sore throat". BMJ Clin Evid. 2007. PMC 2943825. PMID 19450346.
  36. Kumar GG, Mahadevan A, Guruprasad AS, Kovoor JM, Satishchandra P, Nath A, Ranga U, Shankar SK (June 2010). "Eccentric target sign in cerebral toxoplasmosis: neuropathological correlate to the imaging feature". J Magn Reson Imaging. 31 (6): 1469–72. doi:10.1002/jmri.22192. PMC 2908244. PMID 20512900.
  37. [+https://www.cdc.gov/parasites/toxoplasmosis/diagnosis.html "CDC - Toxoplasmosis - Diagnosis"] Check |url= value (help).
  38. "Sarcoidosis | National Heart, Lung, and Blood Institute (NHLBI)".
  39. Mavragani CP, Moutsopoulos HM (October 2014). "Sjögren syndrome". CMAJ. 186 (15): E579–86. doi:10.1503/cmaj.122037. PMC 4203623. PMID 24566651.
  40. Dispenzieri A, Armitage JO, Loe MJ, Geyer SM, Allred J, Camoriano JK, Menke DM, Weisenburger DD, Ristow K, Dogan A, Habermann TM (November 2012). "The clinical spectrum of Castleman's disease". Am. J. Hematol. 87 (11): 997–1002. doi:10.1002/ajh.23291. PMC 3900496. PMID 22791417.
  41. Saeed-Abdul-Rahman I, Al-Amri AM (September 2012). "Castleman disease". Korean J Hematol. 47 (3): 163–77. doi:10.5045/kjh.2012.47.3.163. PMC 3464333. PMID 23071471.
  42. Bosch X, Guilabert A (May 2006). "Kikuchi-Fujimoto disease". Orphanet J Rare Dis. 1: 18. doi:10.1186/1750-1172-1-18. PMC 1481509. PMID 16722618.
  43. AlGhamdi FE, Al-Khatib TA, Marzouki HZ, AlGarni MA (March 2016). "Kimura disease: No age or ethnicity limit". Saudi Med J. 37 (3): 315–9. doi:10.15537/smj.2016.3.14448. PMC 4800898. PMID 26905356.
  44. "Rosai-Dorfman disease | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program".
  45. Foucar E, Rosai J, Dorfman R (February 1990). "Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity". Semin Diagn Pathol. 7 (1): 19–73. PMID 2180012.
  46. "About Kawasaki Disease | Kawasaki Disease | CDC".
  47. "Kawasaki Disease | National Heart, Lung, and Blood Institute (NHLBI)".
  48. Helliwell TR (February 2003). "acp Best Practice No 169. Evidence based pathology: squamous carcinoma of the hypopharynx". J. Clin. Pathol. 56 (2): 81–5. PMC 1769882. PMID 12560383.
  49. International Journal of Recent Scientific Research. doi:10.24327/IJRSR. ISSN 0976-3031. Missing or empty |title= (help)
  50. Maasland, Denise HE; van den Brandt, Piet A; Kremer, Bernd; Goldbohm, R Alexandra; Schouten, Leo J (2014). "Alcohol consumption, cigarette smoking and the risk of subtypes of head-neck cancer: results from the Netherlands Cohort Study". BMC Cancer. 14 (1). doi:10.1186/1471-2407-14-187. ISSN 1471-2407.
  51. Debnath SC, Adhyapok AK (June 2010). "Pleomorphic adenoma (benign mixed tumour) of the minor salivary glands of the upper lip". J Maxillofac Oral Surg. 9 (2): 205–8. doi:10.1007/s12663-010-0052-5. PMC 3244097. PMID 22190789.
  52. Kato H, Kawaguchi M, Ando T, Mizuta K, Aoki M, Matsuo M (August 2018). "Pleomorphic adenoma of salivary glands: common and uncommon CT and MR imaging features". Jpn J Radiol. 36 (8): 463–471. doi:10.1007/s11604-018-0747-y. PMID 29845358.
  53. Chulam TC, Noronha Francisco AL, Goncalves Filho J, Pinto Alves CA, Kowalski LP (December 2013). "Warthin's tumour of the parotid gland: our experience". Acta Otorhinolaryngol Ital. 33 (6): 393–7. PMID 24376295.
  54. "Warthin tumor | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program".
  55. Chen B, Hentzelman JI, Walker RJ, Lai JP (2016). "Oncocytoma of the Submandibular Gland: Diagnosis and Treatment Based on Clinicopathology". Case Rep Otolaryngol. 2016: 8719030. doi:10.1155/2016/8719030. PMC 5045990. PMID 27722003.
  56. Kim KH, Sung MW, Kim JW, Koo JW (July 2000). "Pleomorphic adenoma of the trachea". Otolaryngol Head Neck Surg. 123 (1 Pt 1): 147–8. doi:10.1067/mhn.2000.102809. PMID 10889498.
  57. Pramod Krishna B (June 2013). "Pleomorphic Adenoma of Minor Salivary Gland in a 14 year Old Child". J Maxillofac Oral Surg. 12 (2): 228–31. doi:10.1007/s12663-010-0125-5. PMC 3681990. PMID 24431845.
  58. Kessler AT, Bhatt AA (2018). "Review of the Major and Minor Salivary Glands, Part 2: Neoplasms and Tumor-like Lesions". J Clin Imaging Sci. 8: 48. doi:10.4103/jcis.JCIS_46_18. PMC 6251244. PMID 30546932.
  59. Chenevert J, Barnes LE, Chiosea SI (February 2011). "Mucoepidermoid carcinoma: a five-decade journey". Virchows Arch. 458 (2): 133–40. doi:10.1007/s00428-011-1040-y. PMID 21243374.
  60. Jones AV, Craig GT, Speight PM, Franklin CD (April 2008). "The range and demographics of salivary gland tumours diagnosed in a UK population". Oral Oncol. 44 (4): 407–17. doi:10.1016/j.oraloncology.2007.05.010. PMID 17825603.
  61. Beltran D, Faquin WC, Gallagher G, August M (March 2006). "Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma". J. Oral Maxillofac. Surg. 64 (3): 415–23. doi:10.1016/j.joms.2005.11.027. PMID 16487803.
  62. Mlika M, Kourda N, Zidi Y, Aloui R, Zneidi N, Rammeh S, Zermani R, Jilani SB (January 2012). "Salivary duct carcinoma of the parotid gland". J Oral Maxillofac Pathol. 16 (1): 134–6. doi:10.4103/0973-029X.92992. PMC 3303509. PMID 22434951.
  63. Schmitt NC, Kang H, Sharma A (November 2017). "Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy". Oral Oncol. 74: 40–48. doi:10.1016/j.oraloncology.2017.09.008. PMC 5685667. PMID 29103750.
  64. Simpson RH (July 2013). "Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification". Head Neck Pathol. 7 Suppl 1: S48–58. doi:10.1007/s12105-013-0456-x. PMC 3712088. PMID 23821208.
  65. Manvikar V, Ramulu S, Ravishanker ST, Chakravarthy C (May 2014). "Squamous cell carcinoma of submandibular salivary gland: A rare case report". J Oral Maxillofac Pathol. 18 (2): 299–302. doi:10.4103/0973-029X.140909. PMC 4196305. PMID 25328317.
  66. Ying YL, Johnson JT, Myers EN (July 2006). "Squamous cell carcinoma of the parotid gland". Head Neck. 28 (7): 626–32. doi:10.1002/hed.20360. PMID 16475198.
  67. Wei CH, Harari A (March 2012). "Parathyroid carcinoma: update and guidelines for management". Curr Treat Options Oncol. 13 (1): 11–23. doi:10.1007/s11864-011-0171-3. PMID 22327883.
  68. Sahasranam P, Tran MT, Mohamed H, Friedman TC (August 2007). "Multiglandular parathyroid carcinoma: a case report and brief review". South. Med. J. 100 (8): 841–4. doi:10.1097/SMJ.0b013e318073ca37. PMID 17713315.
  69. Holmes EC, Morton DL, Ketcham AS (April 1969). "Parathyroid carcinoma: a collective review". Ann. Surg. 169 (4): 631–40. PMC 1387475. PMID 4886854.
  70. Sajid MS, Hamilton G, Baker DM (August 2007). "A multicenter review of carotid body tumour management". Eur J Vasc Endovasc Surg. 34 (2): 127–30. doi:10.1016/j.ejvs.2007.01.015. PMID 17400487.
  71. Boedeker CC, Ridder GJ, Schipper J (2005). "Paragangliomas of the head and neck: diagnosis and treatment". Fam. Cancer. 4 (1): 55–9. doi:10.1007/s10689-004-2154-z. PMID 15883711.
  72. Pellitteri PK, Rinaldo A, Myssiorek D, Gary Jackson C, Bradley PJ, Devaney KO, Shaha AR, Netterville JL, Manni JJ, Ferlito A (July 2004). "Paragangliomas of the head and neck". Oral Oncol. 40 (6): 563–75. doi:10.1016/j.oraloncology.2003.09.004. PMID 15063383.
  73. Darouassi Y, Alaoui M, Mliha Touati M, Al Maghraoui O, En-Nouali A, Bouaity B, Ammar H (August 2017). "Carotid Body Tumors: A Case Series and Review of the Literature". Ann Vasc Surg. 43: 265–271. doi:10.1016/j.avsg.2017.03.167. PMID 28478173.
  74. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C (August 2004). "Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations". JAMA. 292 (8): 943–51. doi:10.1001/jama.292.8.943. PMID 15328326.
  75. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, Young WF (November 2001). "Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients". J. Clin. Endocrinol. Metab. 86 (11): 5210–6. doi:10.1210/jcem.86.11.8034. PMID 11701678.
  76. O'Riordain DS, Young WF, Grant CS, Carney JA, van Heerden JA (September 1996). "Clinical spectrum and outcome of functional extraadrenal paraganglioma". World J Surg. 20 (7): 916–21, discussion 922. PMID 8678971.
  77. Hilton DA, Hanemann CO (April 2014). "Schwannomas and their pathogenesis". Brain Pathol. 24 (3): 205–20. doi:10.1111/bpa.12125. PMID 24450866.
  78. Albert P, Patel J, Badawy K, Weissinger W, Brenner M, Bourhill I, Parnell J (2017). "Peripheral Nerve Schwannoma: A Review of Varying Clinical Presentations and Imaging Findings". J Foot Ankle Surg. 56 (3): 632–637. doi:10.1053/j.jfas.2016.12.003. PMID 28237565.
  79. Wong B, Bathala S, Grant D (January 2017). "Laryngeal schwannoma: a systematic review". Eur Arch Otorhinolaryngol. 274 (1): 25–34. doi:10.1007/s00405-016-4013-6. PMID 27020268. Vancouver style error: initials (help)
  80. Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT (December 1982). "Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute". Cancer. 50 (12): 2699–707. PMID 7139563.
  81. Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT (December 1982). "Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute". Cancer. 50 (12): 2699–707. PMID 7139563.
  82. Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S (August 2004). "B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review". Int. J. Cancer. 111 (1): 1–8. doi:10.1002/ijc.20205. PMID 15185336.
  83. Moormeier JA, Williams SF, Golomb HM (February 1990). "The staging of non-Hodgkin's lymphomas". Semin. Oncol. 17 (1): 43–50. PMID 2406917.
  84. Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S (August 2004). "B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review". Int. J. Cancer. 111 (1): 1–8. doi:10.1002/ijc.20205. PMID 15185336.
  85. Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT (December 1982). "Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute". Cancer. 50 (12): 2699–707. PMID 7139563.
  86. Evans HL (January 2007). "Atypical lipomatous tumor, its variants, and its combined forms: a study of 61 cases, with a minimum follow-up of 10 years". Am. J. Surg. Pathol. 31 (1): 1–14. doi:10.1097/01.pas.0000213406.95440.7a. PMID 17197914.
  87. Conyers R, Young S, Thomas DM (2011). "Liposarcoma: molecular genetics and therapeutics". Sarcoma. 2011: 483154. doi:10.1155/2011/483154. PMC 3021868. PMID 21253554.
  88. Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Oliveira AM, Folpe AL (May 2009). "Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age". Am. J. Surg. Pathol. 33 (5): 645–58. doi:10.1097/PAS.0b013e3181963c9c. PMID 19194281.
  89. Serpell JW, Chen RY (July 2007). "Review of large deep lipomatous tumours". ANZ J Surg. 77 (7): 524–9. doi:10.1111/j.1445-2197.2007.04042.x. PMID 17610686.
  90. de Bree E, Karatzanis A, Hunt JL, Strojan P, Rinaldo A, Takes RP, Ferlito A, de Bree R (May 2015). "Lipomatous tumours of the head and neck: a spectrum of biological behaviour". Eur Arch Otorhinolaryngol. 272 (5): 1061–77. doi:10.1007/s00405-014-3065-8. PMID 24800932.
  91. Rydholm A, Berg NO (December 1983). "Size, site and clinical incidence of lipoma. Factors in the differential diagnosis of lipoma and sarcoma". Acta Orthop Scand. 54 (6): 929–34. PMID 6670522.
  92. Myhre-Jensen O (June 1981). "A consecutive 7-year series of 1331 benign soft tissue tumours. Clinicopathologic data. Comparison with sarcomas". Acta Orthop Scand. 52 (3): 287–93. PMID 7282321.
  93. Urquhart AC, Johnson JT, Myers EN, Schechter GL (April 1994). "Glomus vagale: paraganglioma of the vagus nerve". Laryngoscope. 104 (4): 440–5. doi:10.1288/00005537-199404000-00008. PMID 8164483.
  94. Valavanis A, Schubiger O, Oguz M (1983). "High-resolution CT investigation of nonchromaffin paragangliomas of the temporal bone". AJNR Am J Neuroradiol. 4 (3): 516–9. PMID 6308990.
  95. Urquhart AC, Johnson JT, Myers EN, Schechter GL (April 1994). "Glomus vagale: paraganglioma of the vagus nerve". Laryngoscope. 104 (4): 440–5. doi:10.1288/00005537-199404000-00008. PMID 8164483.
  96. Stein PP, Black HR (January 1991). "A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience". Medicine (Baltimore). 70 (1): 46–66. PMID 1988766.
  97. Sajid MS, Hamilton G, Baker DM (August 2007). "A multicenter review of carotid body tumour management". Eur J Vasc Endovasc Surg. 34 (2): 127–30. doi:10.1016/j.ejvs.2007.01.015. PMID 17400487.
  98. Boedeker CC, Ridder GJ, Schipper J (2005). "Paragangliomas of the head and neck: diagnosis and treatment". Fam. Cancer. 4 (1): 55–9. doi:10.1007/s10689-004-2154-z. PMID 15883711.
  99. Gluckman JL, Robbins KT, Fried MP (1990). "Cervical metastatic squamous carcinoma of unknown or occult primary source". Head Neck. 12 (5): 440–3. PMID 2211107.
  100. Waltonen JD, Ozer E, Hall NC, Schuller DE, Agrawal A (October 2009). "Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup". Arch. Otolaryngol. Head Neck Surg. 135 (10): 1024–9. doi:10.1001/archoto.2009.145. PMID 19841343.
  101. Feldman PS, Kaplan MJ, Johns ME, Cantrell RW (November 1983). "Fine-needle aspiration in squamous cell carcinoma of the head and neck". Arch Otolaryngol. 109 (11): 735–42. PMID 6639441.
  102. Grénman R, Koivunen P, Minn H (2015). "[Laryngeal cancer in Finland]". Duodecim (in Finnish). 131 (4): 331–7. PMID 26237923.
  103. Guneyli S, Cinar C, Bozkaya H, Korkmaz M, Oran I (September 2016). "Endovascular management of congenital arteriovenous fistulae in the neck". Diagn Interv Imaging. 97 (9): 871–5. doi:10.1016/j.diii.2015.08.006. PMID 26972281.
  104. Gobin YP, Garcia de la Fuente JA, Herbreteau D, Houdart E, Merland JJ (November 1993). "Endovascular treatment of external carotid-jugular fistulae in the parotid region". Neurosurgery. 33 (5): 812–6. PMID 8264877.
  105. Madjar S, Weissberg D (July 1995). "Retrosternal goiter". Chest. 108 (1): 78–82. PMID 7606997.
  106. Hedayati N, McHenry CR (March 2002). "The clinical presentation and operative management of nodular and diffuse substernal thyroid disease". Am Surg. 68 (3): 245–51, discussion 251–2. PMID 11893102.
  107. Hughes K, Eastman C (August 2012). "Goitre - causes, investigation and management". Aust Fam Physician. 41 (8): 572–6. PMID 23145396.
  108. Hermus AR, Huysmans DA (August 2000). "[Diagnosis and therapy of patients with euthyroid goiter]". Ned Tijdschr Geneeskd (in Dutch; Flemish). 144 (34): 1623–7. PMID 10972051.